NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Evidence reviews for NICE guidelines summarise the evidence, its strengths and limitations and provide a summary of how the NICE guideline committee has interpreted the evidence in light of any uncertainties to make recommendations for practice.
The evidence identified during systematic searches of the published literature and from other sources is reviewed against a pre-specified review protocol to identify the most appropriate evidence to answer the review questions. They address only the key issues and questions covered in the scope of the guideline, and will usually be structured with a recognised framework (for example, using PICO or SPICE).
The evidence review process used to inform NICE guidelines is explicit, transparent and involves 6 main steps:
- Agreeing the review protocol with the NICE guideline committee
- Identifying and selecting relevant evidence
- Critical appraisal of all included evidence
- Extracting and synthesising the results
- Assessing quality/certainty in the evidence
- Interpreting the results.
Further details can be found in Developing NICE guidelines: the manual
Contents
Current
- Emergency management of an adrenal crisis: Adrenal insufficiency: identification and management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Evidence review for diagnostic accuracy of ultrawide-field fundus photography and optical coherence tomography: Diabetic retinopathy: management and monitoring: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Evidence review for effectiveness of treatments before, during or after cataract surgery for managing non-proliferative diabetic retinopathy, proliferative diabetic retinopathy or diabetic macular oedema: Diabetic retinopathy: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Evidence reviews for clinical features or factors that suggest treatment should be switched or stopped for people diagnosed with proliferative diabetic retinopathy or diabetic macular oedema: Diabetic retinopathy: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Evidence reviews for effectiveness of different thresholds or criteria for starting treatment for non-proliferative diabetic retinopathy, proliferative diabetic retinopathy, and diabetic macular oedema: Diabetic retinopathy: management and monitoring: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Evidence reviews for effectiveness of intensive treatments to lower blood glucose levels on progression of diabetic retinopathy and diabetic macular oedema: Diabetic retinopathy: management and monitoring: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Evidence reviews for prognostic factors for progression of non-proliferative diabetic retinopathy to proliferative diabetic retinopathy and diabetic macular oedema: Diabetic retinopathy: management and monitoring: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Evidence reviews for the effectiveness and acceptability of anti-vascular endothelial growth factor agents and laser photocoagulation (alone or in combination) for the treatment of non-proliferative and proliferative diabetic retinopathy: Diabetic retinopathy: management and monitoring: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Evidence reviews for the effectiveness and acceptability of intravitreal steroids, macular laser and anti-vascular endothelial growth factor agents for treating diabetic macular oedema: Diabetic retinopathy: management and monitoring: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Evidence reviews for the effectiveness of different monitoring frequencies: Diabetic retinopathy: management and monitoring: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Evidence reviews for the effectiveness of lipid modification therapies and antihypertensive medicines: Diabetic retinopathy: management and monitoring: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Evidence reviews for vitrectomy: Diabetic retinopathy: management and monitoring: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Information, support and decision making: Adrenal insufficiency: identification and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Methods for corticosteroid withdrawal: Adrenal insufficiency: identification and management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Non-pharmacological strategies to prevent adrenal crisis during periods of intercurrent illness and periods of physiological stress: Adrenal insufficiency: identification and management: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Ongoing care and monitoring of people with adrenal insufficiency: Adrenal insufficiency: identification and management: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Pharmacological management during psychological stress: Adrenal insufficiency: identification and management: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Pharmacological management of physiological stress: Adrenal insufficiency: identification and management: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Routine pharmacological management of secondary and tertiary adrenal insufficiency: Adrenal insufficiency: identification and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- When to refer for specialist investigation when withdrawing corticosteroids: Adrenal insufficiency: identification and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- When to suspect adrenal crisis: Adrenal insufficiency: identification and management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- When to suspect adrenal insufficiency: Adrenal insufficiency: identification and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); August 2024.
- Progesterone for preventing spontaneous preterm birth in twin and triplet pregnancy: Twin and triplet pregnancy: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); April 2024.
- Treatment of endometriosis when fertility is a priority: Endometriosis: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); April 2024.
- Benefits and risks of surveillance: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Carrier probability – any person: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Carrier probability – family history of a syndrome: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Carrier probability – people with ovarian cancer: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Configuration of services: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for antibiotics for bacterial meningitis before or in the absence of identifying causative infecting organism in adults: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review D3London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for antibiotics for bacterial meningitis before or in the absence of identifying causative infecting organism in older infants and children: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review D2London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for antibiotics for bacterial meningitis caused by Gram-negative bacilli: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review E4London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for antibiotics for bacterial meningitis caused by Group B streptococcus: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review E3London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for antibiotics for bacterial meningitis caused by Haemophilus influenzae: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review E2London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for antibiotics for bacterial meningitis caused by Listeria monocytogenes: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review E5London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for antibiotics for bacterial meningitis caused by Neisseria meningitidis: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review E6London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for antibiotics for bacterial meningitis caused by Streptococcus pneumoniae: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review E1London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for antibiotics for meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for corticosteroids for treatment of bacterial meningitis: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review G4London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for corticosteroids in meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for diagnostic tests: Vitamin B12 deficiency in over 16s: diagnosis and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for factors associated with brain herniation: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review B4London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for factors associated with recurrent bacterial meningitis: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review J1London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for factors associated with recurrent bacterial meningitis: Neonatal infection: antibiotics for prevention and treatment: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for factors associated with recurrent meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review J2London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for fluid restriction in bacterial meningitis: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review G1London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for fluid restriction in bacterial meningitis: Neonatal infection: antibiotics for prevention and treatment: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for follow up: Vitamin B12 deficiency in over 16s: diagnosis and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for information and support: Vitamin B12 deficiency in over 16s: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for information for suspected bacterial meningitis or meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review K1London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for intracranial pressure monitoring in bacterial meningitis: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review G3London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for investigating and diagnosing suspected bacterial meningitis with blood and urine investigations: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review B1London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for investigating and diagnosing suspected bacterial meningitis with cerebrospinal fluid parameters: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review B3London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for investigating and diagnosing suspected bacterial meningitis with cerebrospinal fluid parameters: Neonatal infection: antibiotics for prevention and treatment: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for investigating and diagnosing suspected meningococcal disease with blood and urine investigations: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review B2London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for long-term complications and follow-up for bacterial meningitis: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review I1London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for long-term complications and follow-up for bacterial meningitis: Neonatal infection: antibiotics for prevention and treatment: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for long-term complications and follow-up for meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review I2London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for monitoring for gastric cancer in people with vitamin B12 deficiency due to autoimmune gastritis: Vitamin B12 deficiency in over 16s: diagnosis and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for osmotic agents in bacterial meningitis: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review G2London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for risk factors associated with bacterial meningitis: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review A2London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for risk factors associated with meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review A4London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for role of neuroimaging prior to lumbar puncture: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review B5London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for support for suspected bacterial meningitis or meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review K2London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for symptoms and signs associated with bacterial meningitis: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review A1London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for symptoms and signs associated with meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review A3London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for tests for identifying cause: Vitamin B12 deficiency in over 16s: diagnosis and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for timing of antibiotics for meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review C2London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for vitamin B12 replacement: Vitamin B12 deficiency in over 16s: diagnosis and management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review on information for confirmed bacterial meningitis or meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review K3London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review on information for confirmed bacterial meningitis: Neonatal infection: antibiotics for prevention and treatment: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review on information for confirmed bacterial meningitis: Neonatal infection: antibiotics for prevention and treatment: Evidence review PLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review on support for confirmed bacterial meningitis or meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review K4London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review on support for confirmed bacterial meningitis: Neonatal infection: antibiotics for prevention and treatment: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review on support for confirmed bacterial meningitis: Neonatal infection: antibiotics for prevention and treatment: Evidence review QLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence reviews for antibiotics for bacterial meningitis before or in the absence of identifying causative infecting organism in younger infants: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review D1London: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence reviews for risk factors and symptoms and signs for vitamin B12 deficiency: Vitamin B12 deficiency in over 16s: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence reviews for timing of antibiotics for bacterial meningitis: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review C1London: National Institute for Health and Care Excellence (NICE); March 2024.
- Hormone replacement therapy after risk-reducing surgery: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review PLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Information and support: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Methods of surveillance: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Optimal methods of assessing the absolute risk of having a pathogenic variant: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Optimal methods of assessing the probability of having a pathogenic variant: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Pathology protocol: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Populations with high prevalence: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Preventive medicines: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Risk-reducing surgery: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Support interventions: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Which genes to include in gene panel testing: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); March 2024.
- Evidence review for early management of suspected sepsis (except antibiotic therapy) in the NEWS2 population, in acute hospital settings: Sepsis: recognition, diagnosis, and early management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); January 2024.
- Evidence review for managing and treating suspected sepsis in acute hospital settings; antibiotic treatment in people with suspected sepsis: Suspected sepsis: recognition, diagnosis and early management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); January 2024.
- Evidence reviews for further surgery after breast-conserving surgery based on tissue margins: Early and locally advanced breast cancer: diagnosis and management: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); January 2024.
- Evidence reviews for stratifying risk of severe illness or death from sepsis: Suspected sepsis: recognition, diagnosis and early management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); January 2024.
- Placenta accreta spectrum (PAS): Caesarean birth: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); January 2024.
- Evidence review for changes to valproate recommendations after revised MHRA safety advice: Bipolar disorder: assessment and managementLondon: National Institute for Health and Care Excellence (NICE); December 2023.
- Evidence review for escalation of lipid-lowering treatment for secondary prevention of CVD: Cardiovascular disease: risk assessment and reduction, including lipid modification: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); December 2023.
- Evidence review for diagnostic accuracy of point-of-care tests for viral versus bacterial infection: Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence review for rapid tests to inform triage and antibiotic prescribing decisions: Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management: Evidence review BKatie Scandrett, Jill Colquitt, Rachel Court, Fiona Whiter, Bethany Shinkins, Yemisi Takwoingi, Emma Loveman, Daniel Todkill, Paramjit Gill, Daniel Lasserson, Lena Alkhudiary, Amy Grove, and Yen-Fu Chen.London: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence review for signs, symptoms and early warning scores for predicting severe illness: Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for circuit training for walking: Stroke rehabilitation in adults (update): Evidence review LLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for community participation interventions: Stroke rehabilitation in adults: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for computer-based tools for speech and language therapy: Stroke rehabilitation in adults (update): Evidence review KLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for early supported discharge: Stroke rehabilitation in adults (update): Evidence review A1London: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for early supported discharge: Stroke rehabilitation in adults (update): Evidence review A2London: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for early supported discharge: Stroke rehabilitation in adults (update): Evidence review A3London: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for early supported discharge: Stroke rehabilitation in adults (update): Evidence review A4London: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for intensity of rehabilitation - Health economics: Stroke Rehabilitation in adults (update): Evidence review E5London: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for intensity of rehabilitation: Stroke rehabilitation in adults (update): Evidence review E1-4London: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for interventions for shoulder pain after stroke: Stroke rehabilitation in adults: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for interventions for spasticity: Stroke rehabilitation in adults (update): Evidence review PLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for interventions to support eating and drinking for adults after a stroke: Stroke rehabilitation in adults (update): Evidence review ILondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for robot-assisted arm training: Stroke rehabilitation in adults (update): Evidence review MLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for self-management: Stroke rehabilitation in adults (update): Evidence review FLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for the clinical and cost-effectiveness of interventions to support oral hygiene for adults after a stroke: Stroke rehabilitation in adults (update): Evidence review JLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for the clinical and cost-effectiveness of mirror therapy: Stroke rehabilitation in adults (update): Evidence review QLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for the clinical and cost-effectiveness of music therapy for adults after a stroke: Stroke rehabilitation in adults (update): Evidence review NLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for the clinical and cost-effectiveness of routine specialist orthoptist assessment: Stroke rehabilitation in adults (update): Evidence review CLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for the clinical and cost-effectiveness of telerehabilitation for adults after a stroke: Stroke rehabilitation in adults (update): Evidence review GLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for the optimal tool for hearing assessment: Stroke rehabilitation in adults (update): Evidence review DLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence reviews for the optimal tool for the assessment of fatigue: Stroke rehabilitation in adults (update): Evidence review BLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Evidence summary for acute respiratory infection: Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); October 2023.
- Clinical and cost-effectiveness of non-selective beta-blockers and endoscopic variceal band ligation for the primary prevention of bleeding in people with oesophageal varices due to cirrhosis: Cirrhosis in over 16s: assessment and management (update): Evidence review ALondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence review for service configuration and delivery (management and rehabilitation): Spinal metastases and metastatic spinal cord compression: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence review for the clinical and cost effectiveness of non-selective beta-blockers for the primary prevention of decompensation in people with compensated cirrhosis: Cirrhosis in over 16s: assessment and management (update): Evidence review CLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence review for the use of antibiotics to prevent spontaneous bacterial peritonitis: Cirrhosis in over 16s: assessment and management (update): Evidence review BLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for active and physiological management of the third stage: Intrapartum care: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for analgesic interventions: Spinal metastases and metastatic spinal cord compression: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for corticosteroids: Spinal metastases and metastatic spinal cord compression: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for immobilisation: Spinal metastases and metastatic spinal cord compression: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for impact of BMI on choice of place of birth: Intrapartum care: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for information and support: Spinal metastases and metastatic spinal cord compression: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for initial assessment of women reporting prelabour rupture of membranes: Intrapartum care: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for interventions to reduce perineal trauma: Intrapartum care: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for invasive interventions: Spinal metastases and metastatic spinal cord compression: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for investigations – diagnosis: Spinal metastases and metastatic spinal cord compression: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for investigations – management: Spinal metastases and metastatic spinal cord compression: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for pharmacological management of postpartum haemorrhage: Intrapartum care: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for position for birth: Intrapartum care: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for position of the baby during cord clamping: Intrapartum care: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for prognostic tools – overall survival: Spinal metastases and metastatic spinal cord compression: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for prognostic tools – spinal instability: Spinal metastases and metastatic spinal cord compression: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for programmed intermittent epidural bolus: Intrapartum care: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for prophylactic antibiotics for birth with forceps or ventouse: Intrapartum care: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for pushing techniques: Intrapartum care: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for radiotherapy: Spinal metastases and metastatic spinal cord compression: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for recognition – MSCC: Spinal metastases and metastatic spinal cord compression: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for recognition – spinal metastases: Spinal metastases and metastatic spinal cord compression: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for remifentanil patient-controlled analgesia: Intrapartum care: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for route of administration of oxytocin in the third stage of labour: Intrapartum care: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for service configuration and delivery – investigations: Spinal metastases and metastatic spinal cord compression: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for sterile water injections: Intrapartum care: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for use of oxytocin in the first or second stage of labour: Intrapartum care: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for uterotonics for the prevention of postpartum haemorrhage: Intrapartum care: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); September 2023.
- Evidence reviews for adenoidectomy for children with OME: Otitis media with effusion in under 12s: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for antibiotics: Otitis media with effusion in under 12s: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for auto-inflation for children with OME: Otitis media with effusion in under 12s: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for diagnosing VTE in people with COVID-19: NICE guideline Venous thromboembolic diseases: diagnosis, management, and thrombophilia testing: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for follow-up strategy after surgical treatment for OME-related hearing loss: Otitis media with effusion in under 12s: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for hearing aids/devices for hearing loss associated with OME in children under 12 years: Otitis media with effusion in under 12s: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for information for suspected or confirmed OME: Otitis media with effusion in under 12s: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for natural history of OME without hearing loss: Otitis media with effusion in under 12s: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for natural history of OME-related hearing loss: Otitis media with effusion in under 12s: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for non-antimicrobial pharmacological interventions for children with OME: Otitis media with effusion in under 12s: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for presenting features associated with OME in children: Otitis media with effusion in under 12s: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for preventing otorrhoea after surgery for hearing loss associated with OME in children: Otitis media with effusion in under 12s: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for the modifiable risk factors for developing OME in children: Otitis media with effusion in under 12s: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for treating otorrhoea after surgery for hearing loss associated with OME in children: Otitis media with effusion in under 12s: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence reviews for ventilation tubes: Otitis media with effusion in under 12s: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Medical management of miscarriage: Ectopic pregnancy and miscarriage: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Surgical opening technique: Caesarean birth: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); August 2023.
- Evidence review for referral for bariatric surgery: Weight management suite: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); July 2023.
- Evidence reviews for the management of luminal obstruction in adults with oesophageal cancer not amenable to treatment with curative intent: Oesophago-gastric cancer: assessment and management in adults: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); July 2023.
- Evidence review for the effectiveness of different external beam hypofractionation radiotherapy regimens in people with early-stage or locally advanced invasive breast cancer: Early and locally advanced breast cancer: diagnosis and management: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); June 2023.
- Evidence reviews for adding bath emollients to the management of atopic eczema in children under 12 years: Atopic eczema in under 12s: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); June 2023.
- Evidence review for admission and observation in hospital of people with head injury who are on anticoagulant or antiplatelet therapy after normal brain imaging or no indication for early imaging: Head injury: assessment and early management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence review for admission and observation of people with concussion symptoms: Head injury: assessment and early management: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence review for CT, MRI and X-ray of the cervical spine in people with head injury diagnostic: Head injury: assessment and early management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence review for CVD risk assessment tools: primary prevention: Cardiovascular disease: risk assessment and reduction, including lipid modification: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence review for CVD risk assessment tools: primary prevention: Cardiovascular disease: risk assessment and reduction, including lipid modification: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence review for dietary cholesterol strategies: Cardiovascular disease: risk assessment and reduction, including lipid modification: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence review for dietary cholesterol strategies: Cardiovascular disease: risk assessment and reduction, including lipid modification: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence review for glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes: Diabetes (type 1 and 2) in children and young people: diagnosis and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence review for hospital admission in people with small intracranial injuries: Head injury: assessment and early management: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence review for identification of hypopituitarism (who to investigate): Head Injury: assessment and early management: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence review for statins: efficacy and adverse effects: Cardiovascular disease: risk assessment and reduction, including lipid modification: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence review for statins: efficacy and adverse effects: Cardiovascular disease: risk assessment and reduction, including lipid modification: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence reviews for brain injury biomarkers and/or MRI for predicting post-concussion syndrome: Head injury: assessment and early management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence reviews for brain injury biomarkers for predicting acute post-brain injury complications: Head injury: assessment and early management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence reviews for clinical decision rules selecting people with head injury for imaging: Head injury: assessment and early management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence reviews for direct access from the community to imaging: Head injury: assessment and early management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence reviews for identification of hypopituitarism (when to investigate): Head Injury: assessment and early management: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence reviews for isolated skull fracture: NICE guideline Head injury: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence reviews for selecting adults, children and infants with head injury for CT or MRI head scan in sub-groups: Head Injury: assessment and early management (update): Evidence review ELondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence reviews for tranexamic acid: Head injury: assessment and early management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence reviews for transport to a distant specialist neuroscience centre: Head injury: assessment and early management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); May 2023.
- Evidence reviews for strategies for reducing arm and shoulder problems after breast cancer surgery or radiotherapy: Early and locally advanced breast cancer: diagnosis and management: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); April 2023.
- Evidence review for anti-reflux surgery to induce remission of disease or prevent recurrence: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for anti-reflux surgery to reduce progression to dysplasia or cancer: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for diagnostic accuracy of endoscopic surveillance techniques: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for endoscopic and radiological follow-up after treatment: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for endoscopic and radiological staging techniques: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for endoscopic surveillance using white light endoscopy: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for endoscopic treatment (high-grade dysplasia and stage 1 adenocarcinoma): Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for endoscopic treatment (low-grade dysplasia and indefinite dysplasia): Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for frequency and duration of endoscopic surveillance: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for non-endoscopic surveillance techniques: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for non-surgical treatment for T1b oesophageal adenocarcinoma: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for oesophagectomy versus endoscopic treatment: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for patient information and support: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for pharmacological interventions to reduce progression to dysplasia or cancer: Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); February 2023.
- Evidence review for diagnostic accuracy of tests to identify delirium: Delirium: prevention, diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); January 2023.
- Evidence reviews for femoral component design used for hemiarthroplasties: Hip fracture: management (update): Evidence review ALondon: National Institute for Health and Care Excellence (NICE); January 2023.
- Evidence reviews for risk assessment models and tools for predicting the development of diabetic foot problems and foot review frequency: Diabetic foot problems: prevention and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); January 2023.
- Evidence reviews for total hip replacement versus hemiarthroplasty: Hip fracture: management (update): Evidence review BLondon: National Institute for Health and Care Excellence (NICE); January 2023.
- Evidence review for activity of radioactive iodine after thyroidectomy: Thyroid cancer: assessment and management: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for diagnostic accuracy offine needle aspiration cytology: Thyroid cancer: assessment and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for duration of thyroid stimulating hormone suppression: Thyroid cancer: assessment and management: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for efficacy of repeat fine needle aspiration cytology, active surveillance or discharge: Thyroid cancer: assessment and management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for external beam radiotherapy versus no external beam radiotherapy: Thyroid cancer: assessment and management: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for fetal blood sampling: Fetal monitoring in labour: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for imaging for further staging: Thyroid cancer: assessment and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for indications for blood tests: Thyroid cancer: assessment and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for initial treatments for differentiated thyroid cancer: Thyroid cancer: assessment and management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for length and frequency of follow up: Thyroid cancer: assessment and management: Evidence review QLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for measurement of thyroglobulin: Thyroid cancer: assessment and management: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for molecular testing: Thyroid cancer: assessment and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for radioactive iodine versus no radioactive iodine: Thyroid cancer: assessment and management: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for radioisotope scan: Thyroid cancer: assessment and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for stimulated or highly sensitive thyroglobulin assays: Thyroid cancer: assessment and management: Evidence review PLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for the information, education and support needed by people with suspected and confirmed thyroid cancer, and their families and carers: Thyroid cancer: assessment and management: Evidence review RLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for thyroid stimulating hormone (TSH) suppression versus no TSH suppression: Thyroid cancer: assessment and management: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence review for thyrotropin alfa: Thyroid cancer: assessment and management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Evidence reviews for ultrasound accuracy and threshold of nodule size and classification: Thyroid cancer: assessment and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); December 2022.
- Enabling and supporting effective advocacy: Advocacy services for adults with health and social care needs: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for detecting hydrocephalus: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for detecting intracranial hypertension: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for diagnostic accuracy of investigations: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for diagnostic imaging strategies: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for imaging strategies for follow-up: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for interventions to prevent re-bleeding: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for investigating relatives of people with aneurysmal subarachnoid haemorrhage: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review YLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for management of delayed cerebral ischemia: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for managing hydrocephalus: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for managing intracranial hypertension: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for medical management strategies: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for monitoring for raised intracranial pressure and vasospas: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for negative pressure wound therapy for temporary closure of open fractures: Fractures (complex): assessment and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for non-culprit aneurysms: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review PLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for patient information: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review SLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for risk of subsequent subarachnoid haemorrhage: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for severity scoring systems: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for symptoms and signs: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for the benefit of weight loss for the management of osteoarthritis for people living with overweight or obesity: Osteoarthritis in over 16s: diagnosis and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for the clinical and cost-effectiveness of exercise for the management of osteoarthritis: Osteoarthritis in over 16s: diagnosis and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for timing of interventions to prevent rebleeding: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review on long-term medication for managing the consequences of SAH: Subarachnoid haemorrhage: Evidence review RLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence reviews for long-term medicines for reducing the risk of subsequent subarachnoid haemorrhage: Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management: Evidence review QLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Improving access to advocacy: Advocacy services for adults with health and social care needs: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Information about effective advocacy and signposting to services: Advocacy services for adults with health and social care needs: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Monitoring services and collecting data for quality improvement: Advocacy services for adults with health and social care needs: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Partnership working and relationships with families and carers, commissioners and providers: Advocacy services for adults with health and social care needs: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Planning and commissioning services for advocacy: Advocacy services for adults with health and social care needs: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Training and skills for practitioners who work with advocates: Advocacy services for adults with health and social care needs: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Training, skills and support for advocates: Advocacy services for adults with health and social care needs: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); November 2022.
- What does effective advocacy look like? Advocacy services for adults with health and social care needs: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Who else would benefit from advocacy and how do we identify them? Advocacy services for adults with health and social care needs: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Who has a legal right to advocacy? Advocacy services for adults with health and social care needs: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); November 2022.
- Evidence review for additional benefit of imaging in the diagnosis of osteoarthritis: Osteoarthritis in over 16s: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for post-diagnostic information on osteoarthritis for people with osteoarthritis, their family and carers: Osteoarthritis in over 16s: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for regular follow-up and review: Osteoarthritis in over 16s: diagnosis and management: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for the clinical and cost effectiveness of arthroscopic procedures for the management of osteoarthritis: Osteoarthritis in over 16s: diagnosis and management: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for the clinical and cost effectiveness of devices for the management of osteoarthritis: Osteoarthritis in over 16s: diagnosis and management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for the clinical and cost effectiveness of electrotherapy for the management of osteoarthritis: Osteoarthritis in over 16s: diagnosis and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for the clinical and cost effectiveness of imaging during the management of osteoarthritis: Osteoarthritis in over 16s: diagnosis and management: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for the clinical and cost effectiveness of oral, topical and transdermal medicines for the management of osteoarthritis: Osteoarthritis in over 16s: diagnosis and management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for the clinical and cost-effectiveness of acupuncture for people with osteoarthritis: Osteoarthritis in over 16s: diagnosis and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for the clinical and cost-effectiveness of intra-articular injections for the management of osteoarthritis: Osteoarthritis in over 16s: diagnosis and management: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for the clinical and cost-effectiveness of manual therapy for the management of osteoarthritis: Osteoarthritis in over 16s: diagnosis and management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for the clinical and cost-effectiveness of treatment packages for the management of osteoarthritis: Osteoarthritis in over 16s: diagnosis and management: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence reviews for outcomes of joint replacement surgery dependent on body mass index: Osteoarthritis in over 16s: diagnosis and management: Evidence review PLondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence reviews for the indicators for referral for possible joint replacement surgery: Osteoarthritis in over 16s: diagnosis and management: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); October 2022.
- Evidence review for accuracy of anthropometric measures in assessing health risks associated with overweight and obesity in adults: Weight management suite: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for accuracy of anthropometric measures in assessing health risks associated with overweight and obesity in children and young people: Weight management suite: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for admission to hospital: Self-harm: assessment, management and preventing recurrence: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for assessment in non-specialist settings: Self-harm: assessment, management and preventing recurrence: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for assessment in specialist settings: Self-harm: assessment, management and preventing recurrence: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for consent, confidentiality and safeguarding: Self-harm: assessment, management and preventing recurrence: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for harm minimisation strategies: Self-harm: assessment, management and preventing recurrence: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for information and support needs of families and carers of people who have self-harmed: Self-harm: assessment, management and preventing recurrence: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for information and support needs of people who have self-harmed: Self-harm: assessment, management and preventing recurrence: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for initial after-care: Self-harm: assessment, management and preventing recurrence: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for involving family and carers in the management of people who have self-harmed: Self-harm: assessment, management and preventing recurrence: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for risk assessment and formulation: Self-harm: assessment, management and preventing recurrence: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for safer prescribing: Self-harm: assessment, management and preventing recurrence: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for skills required by staff in non-specialist settings: Self-harm: assessment, management and preventing recurrence: Evidence review RLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for skills required by staff in specialist settings: Self-harm: assessment, management and preventing recurrence: Evidence review PLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence review for therapeutic risk taking strategies: Self-harm: assessment, management and preventing recurrence: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence reviews for models of care for people who have self-harmed: Self-harm: assessment, management and preventing recurrence: Evidence review TLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence reviews for pharmacological interventions: Self-harm: assessment, management and preventing recurrence: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence reviews for psychological and psychosocial interventions: Self-harm: assessment, management and preventing recurrence: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence reviews for supervision required for staff in non-specialist settings: Self-harm: assessment, management and preventing recurrence: Evidence review SLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence reviews for supervision required for staff in specialist mental health settings: Self-harm: assessment, management and preventing recurrence: Evidence review QLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Evidence reviews for supporting people to be safe after self-harm: Self-harm: assessment, management and preventing recurrence: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); September 2022.
- Effectiveness and cost-effectiveness of Allen Carr’s Easyway: Tobacco: preventing uptake, promoting quitting and treating dependence: Evidence review PLondon: National Institute for Health and Care Excellence (NICE); August 2022.
- A cost-consequence and cost-benefit analysis of interventions to improve social, emotional and mental wellbeing in schools: Social, Emotional and Mental Wellbeing in Primary and Secondary Education: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence review for risk factors for poor social, emotional and mental wellbeing: Social, emotional and mental wellbeing in primary and secondary education: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence review for symptoms and signs: Urinary tract infection in under 16s: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence review for targeted social and emotional support: Social, emotional and mental wellbeing in primary and secondary education: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence review for the use of sentinel lymph node biopsy in people with melanoma: Melanoma: assessment and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence review for universal curriculum approaches: Social, emotional, and mental wellbeing in primary and secondary education: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence reviews for completion lymphadenectomy for micrometastatic nodal disease in stage III melanoma: Melanoma: assessment and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence reviews for genetic testing for melanoma: Melanoma: assessment and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence reviews for interventions to support children and young people during periods of transition: Social, emotional and mental wellbeing in primary and secondary education: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence reviews for risk factors for poor social, emotional and mental wellbeing: Social, emotional and mental wellbeing in primary and secondary education: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence reviews for surgical and histological excision margins for people with stage 0 to II melanoma: Melanoma: assessment and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence reviews for systemic and localised anticancer treatment for people with stage IV and unresectable stage III melanoma: Melanoma: assessment and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence reviews for targeted mental health support: Social, emotional and mental wellbeing in primary and secondary education: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence reviews for the follow-up of people with melanoma: Melanoma: assessment and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence reviews for the use of sentinel lymph node biopsy for people with stage III melanoma with microsatellite lesions: Melanoma: assessment and management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Evidence reviews for whole-school approaches: Social, emotional and mental wellbeing in primary and secondary education: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Expert testimony: Social, emotional and mental wellbeing in primary and secondary education: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Qualitative evidence synthesis for universal curriculum approaches: Social, emotional and mental wellbeing in primary and secondary education: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Qualitative review for risk factors for poor social, emotional, and mental wellbeing: Social, emotional and mental wellbeing in primary and secondary education: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); July 2022.
- Access to services: Depression in adults: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Chronic depression: Depression in adults: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Depression with coexisting personality disorder: Depression in adults: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Effective and cost-effective interventions to increase frequent STI testing in very high risk groups: Reducing sexually transmitted infections (STIs): Evidence review DLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Effectiveness, acceptability and cost effectiveness of strategies to improve uptake of STI testing: Reducing sexually transmitted infections (STIs): Evidence review CLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Effectiveness, cost effectiveness, acceptability and unintended consequences of pre-exposure prophylaxis (PrEP) for HIV: Reducing sexually transmitted infections (STIs): Evidence review GLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review D for periodontal treatment to improve diabetic control in adults with type 1 or type 2 diabetes: Periodontal treatment to improve diabetic control in adults with type 1 or type 2 diabetes: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for effectiveness of repeat courses of maternal corticosteroids for fetal lung maturation: Preterm labour and birth: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for follow-up for people with gout after a gout flare: Gout: diagnosis and management: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for ivermectin: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for non-pharmacological management of fatigue: Multiple sclerosis in adults: management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for non-pharmacological management of memory and cognitive problems: Multiple sclerosis in adults: management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for optimum frequency of monitoring: Gout: diagnosis and management: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for patient information: Gout: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for pharmacological management of ataxia and tremor: Multiple sclerosis in adults: management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for pharmacologicalmanagement of mobility problems: Multiple sclerosis in adults: management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for pharmacologicalmanagement of spasticity: Multiple sclerosis in adults: management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for remdesivir for people in hospital: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review PLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for surgical excision of tophi: Gout: diagnosis and management: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for the best serum urate level target to use when treating-to-target in gout? Gout: diagnosis and management: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for the pharmacologicalmanagement of fatigue: Multiple sclerosis in adults: management: Evidence review DGuideline Updates Team (UK).London: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for what signs and symptoms indicate gout as a possible diagnosis? Gout: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review referral to specialist services: Gout: diagnosis and management: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence reviews for colchicine, NSAIDs, corticosteroids and IL-1 inhibitors for the prevention of gout flares during the initiation or titration of urate-lowering therapy: Gout: diagnosis and management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence reviews for coordination of care: the role of MS nurse specialists and other healthcare professionals: Multiple sclerosis in adults: management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence reviews for diet and lifestyle modifications for managing gout: Gout: diagnosis and management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence reviews for information and support for patients (including people who may become pregnant), their families and carers: Multiple sclerosis in adults: management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence reviews for non-pharmacological management of pain: Multiple sclerosis in adults: management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence reviews for pharmacological and non-pharmacological interventions for managing gout flares: Gout: diagnosis and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence reviews for timing of urate-lowering therapy in relation to a flare in people with gout: Gout: diagnosis and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence reviews for treat-to-target management: Gout: diagnosis and management: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence reviews for urate-lowering therapies for the long-term management of gout: Gout: diagnosis and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence reviews for what are the most accurate and cost-effective approaches to diagnosing gout, in particular serum urate level compared with joint aspiration? Gout: diagnosis and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence reviews for which people with gout should be offered a urate-lowering therapy: Gout: diagnosis and management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Further-line treatment: Depression in adults: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Increasing uptake of hepatitis A, hepatitis B and human papillomavirus (HPV) vaccinations in gay, bisexual and other men who have sex with men: Reducing sexually transmitted infections (STIs): Evidence review FLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Interventions to reduce the acquisition and transmission of STIs in higher risk groups: Reducing sexually transmitted infections (STIs): Evidence review ALondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Partner notification methods to prevent or reduce STIs: Reducing sexually transmitted infections (STIs): Evidence review ELondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Patient Choice: Depression in adults: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Periodontal treatment to improve diabetic control in children and young people with type 1 or type 2 diabetes: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Preventing relapse: Depression in adults: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Psychotic depression: Depression in adults: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Qualitative evidence synthesis for the acceptability of interventions for reducing or preventing the acquisition and transmission of STIs: Reducing sexually transmitted infections (STIs): Evidence review BLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Service delivery Models and settings for delivery of services: Depression in adults: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Treatment of a new episode of depression: Depression in adults: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); June 2022.
- Evidence review for baricitinib: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Evidence review for COVID-19 call for evidence: Vaccine uptake in the general population: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2022.
- Evidence review for education interventions to increase the uptake of routine vaccines: Vaccine uptake in the general population: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Evidence review for identification and recording of vaccination eligibility and status: Vaccine uptake in the general population: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Evidence review for interventions to increase the uptake of routine vaccines by improving access: Vaccine uptake in the general population: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Evidence review for interventions to increase the uptake of routine vaccines by improving infrastructure: Vaccine uptake in the general population: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Evidence review for interventions to increase the uptake of routine vaccines for pregnant women: Vaccine uptake in the general population: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Evidence review for multicomponent interventions to increase the uptake of routine vaccines: Vaccine uptake in the general population: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Evidence review for reminders interventions to increase the uptake of routine vaccines: Vaccine uptake in the general population: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Evidence review for the acceptability and effectiveness of interventions to increase routine vaccine uptake: Vaccine uptake in the general population: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Evidence review for the barriers to, and facilitators for, vaccine uptake: Vaccine uptake in the general population: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Evidence review for vitamin D: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Helping people connect with local communities: Social work with adults experiencing complex needs: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Individual or family casework: Social work with adults experiencing complex needs: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Integrated working: Social work with adults experiencing complex needs: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Interventions to increase vaccine uptake by targeting acceptability: Vaccine uptake in the general population: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Needs assessment: Social work with adults experiencing complex needs: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Risk assessment: Social work with adults experiencing complex needs: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Support during an escalation of need: Social work with adults experiencing complex needs: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Supporting changing needs: Social work with adults experiencing complex needs: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); May 2022.
- Add-on therapy for generalised tonic-clonic and focal onset seizures: Epilepsies in children, young people and adults: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Antibody testing in epilepsy: Epilepsies in children, young people and adults: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Computed tomography scan performance in people with epilepsy: Epilepsies in children, young people and adults: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Criteria for referral to specialist services: Epilepsies in children, young people and adults: Evidence review NNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Discontinuation of pharmacological treatment: Epilepsies in children, young people and adults: Evidence review MNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Effectiveness of a nurse specialist in the management of epilepsy: Epilepsies in children, young people and adults: Evidence review ONational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Effectiveness of antiseizure medications for self-limited epilepsy with centrotemporal spikes: Epilepsies in children, young people and adults: Evidence review QNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Effectiveness of antiseizure therapies for epilepsy with myoclonic-atonic seizures (Doose syndrome): Epilepsies in children, young people and adults: Evidence review RNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Effectiveness of antiseizure therapies for infantile spasms: Epilepsies in children, young people and adults: Evidence review PNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Effectiveness of antiseizure therapies in the treatment of absence seizures: Epilepsies in children, young people and adults: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Effectiveness of antiseizure therapies in the treatment of Dravet syndrome: Epilepsies in children, young people and adults: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Effectiveness of antiseizure therapies in the treatment of idiopathic generalised epilepsies, including juvenile myoclonic epilepsy: Epilepsies in children, young people and adults: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Effectiveness of antiseizure therapies in the treatment of Lennox-Gastaut syndrome: Epilepsies in children, young people and adults: Evidence review LNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Effectiveness of antiseizure therapies in the treatment of myoclonic seizures: Epilepsies in children, young people and adults: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Effectiveness of antiseizure therapies in the treatment of tonic or atonic seizures/drop attacks: Epilepsies in children, young people and adults: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Effectiveness of genetic testing in determining the aetiology of epilepsy: Epilepsies in children, young people and adults: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Antiseizure medication for prolonged seizures: monotherapy: Epilepsies in children, young adults and adults: diagnosis and management: Evidence review 11National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Antiseizure medication for status epilepticus: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 9National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Antiseizure medications for repetitive/cluster seizures: monotherapy and add-on therapies: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 10National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Diagnosis of epilepsies: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 3National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Information and support: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 4National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Ketogenic diets for drug-resistant epilepsy: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 12National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Modifiable risk factors for a second seizure: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 2National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Modifiable risk factors for epilepsy related mortality: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 18National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Monitoring: content and frequency: Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: New technologies: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 5National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Optimum prescribing strategies or interventions delivered alongside prescribing: Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Patient information and support: Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Prediction of death, including SUDEP, in people with epilepsy: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 17National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Prediction of second seizure: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 1National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Prevalence of psychological disorders in people with epilepsies: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 15National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Psychological treatments for people with epilepsies: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 16National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Reducing the risk of seizure-related mortality, including SUDEP: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 19National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Risk factors for dependence: Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Safe withdrawal: Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Safety of antiseizure medications in women and girls: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 6National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Therapeutic drug monitoring in women and girls: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 8National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Transition from paediatric to adult epilepsy services: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 20National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Vagus nerve stimulation: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 14National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence review: Withdrawal symptoms: Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence reviews for monitoring: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 7National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Evidence reviews for surgery: referral and surgical interventions: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 13National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Magnetic resonance imaging scan to detectrelevant abnormalities in people with epilepsy: Epilepsies in children, young people and adults: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Monotherapy for generalised tonic-clonic and focal onset seizures: Epilepsies in children, young people and adults: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2022.
- Barriers and facilitators to the implementation and delivery of interventions to improve and protect mental wellbeing at work: Mental wellbeing at work: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Economic modelling for interventions to prevent poor, promote positive and improve mental wellbeing: Mental wellbeing at work: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for awake prone positioning: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for blood pressure targets: Hypertension in adults (update): Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for involving children and young people: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for palliative and end of life care: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for planning and managing transition from children’s to adults’ services: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for preparation for employment: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for promoting and maintaining inclusion, independence and wellbeing: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for respiratory support strategies: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for suitability and accessibility of environments: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for supporting families and carers: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for supporting participation in education and social activities: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for views and experiences of health and social care for people experiencing homelessness: Integrated health and social care for people experiencing homelessness: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for views and experiences of service users: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review of barriers and facilitators of joined-up care: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review of views and experiences of service providers: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review MNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence reviews for combined approaches to identifying, assessing and monitoring health, social care and education needs: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence reviews for commissioning, practice and service delivery models: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence reviews for continuous glucose monitoring in adults with type 1 diabetes: Type 1 diabetes in adults: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence reviews for continuous glucose monitoring in adults with type 2 diabetes: Type 2 diabetes in adults: diagnosis and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence reviews for continuous glucose monitoring in children and young people with type 1 diabetes: Type 1 diabetes in children and young people: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence reviews for diagnosis of diabetes: Type 1 diabetes in adults: diagnosis and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence reviews for effectiveness of approaches to improve access to and engagement with health and social care and joined up approaches: Integrated health and social care for people experiencing homelessness: Evidence review A-BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence reviews for enabling professionals to meet the needs of children and young people: Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across education, health and social care: Evidence review LNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence summary for pharmacological treatment in CVD: Hypertension in adults (update): Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2022.
- Expert testimony: Mental wellbeing at work: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Manager interventions: Mental wellbeing at work: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Organisational universal-level approaches: Mental wellbeing at work: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Targeted individual-level approaches: Mental wellbeing at work: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Targeted organisational-level approaches: Mental wellbeing at work: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Universal individual-level approaches: Mental wellbeing at work: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); March 2022.
- Evidence review for early remdesivir: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); February 2022.
- Evidence review for molnupiravir: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review QLondon: National Institute for Health and Care Excellence (NICE); February 2022.
- Pharmacological therapies with cardiovascular and other benefits in people with type 2 diabetes: Type 2 diabetes: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); February 2022.
- Cognitive interventions for people with complex rehabilitation needs after traumatic injury: Rehabilitation after traumatic injury: Evidence review B.2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Evidence reviews for selective laser trabeculoplasty in ocular hypertension or chronic open-angle glaucoma adult patients: Glaucoma: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); January 2022.
- Identification and assessment of rehabilitation needs after traumatic injury: Rehabilitation After Traumatic Injury: Evidence review A.1/A.2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Physical interventions for people with complex rehabilitations needs after traumatic injury: Rehabilitation after traumatic injury: Evidence review B.1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Psychological and psychosocial interventions for people with complex rehabilitation needs after traumatic injury: Rehabilitation after traumatic injury: Evidence review B.3National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Rehabilitation interventions relating to participation in society for people with complex rehabilitation needs after traumatic injury: Rehabilitation after traumatic injury: Evidence review B.4National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Service coordination: barriers and facilitators to accessing rehabilitation services following discharge to the community: Rehabilitation after traumatic injury: Evidence review D.3National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Service coordination: Inpatient settings for people with complex rehabilitation needs after traumatic injury: Rehabilitation after traumatic injury: Evidence review D.1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Service coordination: inpatient to outpatient settings for people with complex rehabilitation needs after traumatic injury: Rehabilitation after traumatic injury: Evidence review D.2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Service coordination: support needs and preferences following discharge to outpatient or community rehabilitation services for people with complex rehabilitation needs after traumatic injury: Rehabilitation after traumatic injury: Evidence review D.4National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Specific programmes and packages in amputation for people with complex rehabilitation needs after traumatic injury: Rehabilitation after traumatic injury: Evidence review C.1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Specific programmes and packages in chest injury for people with complex rehabilitation needs after traumatic injury: Rehabilitation after traumatic injury: Evidence review C.4National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Specific programmes and packages in nerve injury for people with complex rehabilitation needs after traumatic injury: Rehabilitation after traumatic injury: Evidence review C.2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2022.
- Specific programmes and packages in spinal cord injury for people with complex rehabilitation needs after traumatic injury: Rehabilitation after traumatic injury: Evidence review C.3London: National Institute for Health and Care Excellence (NICE); January 2022.
- Assessment in non-specialist care: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Behavioural approaches to the management of symptoms: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review PNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Co-existing long-term conditions and pelvic floor dysfunction: Pelvic Floor Dysfunction: prevention and non-surgical management: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Community information strategies: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Community-based multidisciplinary teams: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review RNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Dietary factors for the management of symptoms: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Evidence review COVID-19 Associated Pulmonary Aspergillosis (CAPA) – Diagnostics: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); December 2021.
- Evidence reviews for COVID-19 Associated Pulmonary Aspergillosis (CAPA) – Effectiveness and Safety of Treatments: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); December 2021.
- Evidence reviews for COVID-19 Associated Pulmonary Aspergillosis (CAPA) – Risk Factors and Signs and Symptoms: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); December 2021.
- Evidence reviews for diagnostic accuracy of prostate specific antigen (PSA) thresholds for referring people with suspected prostate cancer: Suspected cancer: recognition and referral: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); December 2021.
- Evidence reviews for risk stratification of localised prostate cancer: Prostate cancer: diagnosis and management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); December 2021.
- Information provision about management of pelvic floor dysfunction (most effective ways): Pelvic floor dysfunction: prevention and non-surgical management: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Information provision related to the management of pelvic floor dysfunction (people’s views and experiences): Pelvic floor dysfunction: prevention and non-surgical management: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Lifestyle factors for the prevention of pelvic floor dysfunction: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Pelvic floor muscle training for the management of symptoms: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review MNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Pelvic floor muscle training for the prevention of pelvic floor dysfunction: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Pharmacological management: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review QNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Physical activity for the management of symptoms: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review LNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Physical devices for the management of pelvic floor dysfunction: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review NNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Prediction tools for pelvic floor dysfunction: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Psychological therapy for women with pelvic floor dysfunction: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review ONational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Risk factors for pelvic floor dysfunction: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Weight loss interventions: Pelvic floor dysfunction: prevention and non-surgical management: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2021.
- Evidence review A for SGLT2 inhibitors for people with chronic kidney disease and type 2 diabetes: Type 2 diabetes in adults: management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); November 24, 2021.
- Barriers to and the facilitators of, timely referral to specialist care: COVID-19 rapid evidence review: Managing the long-term effects of COVID-19: Evidence reviewEdinburgh: Healthcare Improvement Scotland; November 2021.
- Case definition: COVID-19 rapid evidence review: Managing the long-term effects of COVID-19: Evidence reviewLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for anticoagulant and/or antiplatelet therapy for biological prosthetic valves and after valve repair: Heart valve disease presenting in adults: investigation and management: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for case definition: COVID-19 rapid guideline: managing the long-term effects of COVID-19: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for cessation and harm-reduction treatments: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for children and young people: COVID-19 rapid guideline: managing the long-term effects of COVID-19: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for colchicine: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for CT and MRI indications for intervention: Heart valve disease presenting in adults: investigation and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for indications for intervention: Heart valve disease presenting in adults: investigation and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for indications for referral to a specialist following echocardiography: Heart valve disease presenting in adults: investigation and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for information and advice: Heart valve disease presenting in adults: investigation and management: Evidence review LNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for inhaled budesonide: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for long-term health effects of e-cigarettes: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for monitoring in people with repaired or replaced heart valves: Heart valve disease presenting in adults: investigation and management: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for monitoring of people with heart valve disease and no current indication for intervention: Heart valve disease presenting in adults: investigation and management: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for repeat intervention for failure of biological or repaired valves: Heart valve disease presenting in adults: investigation and management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for stress testing and stress echocardiography in determining need for intervention: Heart valve disease presenting in adults: investigation and management: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for symptoms and signs indicating need for echocardiography or direct referral to a specialist: Heart valve disease presenting in adults: investigation and management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for tailored interventions for those with mental health conditions: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence review for transcatheter intervention, surgery or conservative management in heart valve disease: Heart valve disease presenting in adults: investigation and management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for barriers and facilitators to using e-cigarettes for cessation or harm reduction: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for e-cigarettes and young people: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review F and GLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for impact of vaccines (update): COVID-19 rapid guideline: managing the long-term effects of COVID-19: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for incentives during pregnancy: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for mass media and prevention: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review A and BLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for nicotine replacement therapies and e-cigarettes in pregnancy: update: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for opt-out stop smoking support: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for pharmacological management: Heart valve disease presenting in adults: investigation and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for reducing proxy purchasing of tobacco and reducing illicit supply of tobacco: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review C and DLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for risk factors (update): COVID-19 rapid guideline: managing the long-term effects of COVID-19: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for signs and symptoms (update): COVID-19 rapid guideline: managing the long-term effects of COVID-19: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for Smokefree Class Competitions: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Evidence reviews for smoking relapse prevention: Tobacco: preventing uptake, promoting quitting and treating dependence: update: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Induction of labour for prevention of prolonged pregnancy: Inducing labour: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); November 2021.
- Induction of labour for suspected fetal macrosomia: Inducing labour: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); November 2021.
- Intrauterine fetal death after previous caesarean birth: Inducing labour: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); November 2021.
- Methods for the induction of labour: Inducing labour: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); November 2021.
- Progestogens for preventing miscarriage: Ectopic pregnancy and miscarriage: diagnosis and initial management: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); November 2021.
- Accessing health and social care services: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2021.
- Appendices for the management of ME/CFS: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2021.
- Barriers and facilitators for promoting physical, mental and emotional health and wellbeing of looked-after children and young people and care leavers: Looked-After Children and Young People: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Barriers and facilitators for supporting care placement stability among looked-after children and young people: Looked-After Children and Young People: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Barriers and facilitators for supporting positive relationships among looked-after children and young people: Looked-After Children and Young People: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Barriers to, and facilitators for, supporting and developing looked-after young people to transition out of care into independent living: Looked-After Children and Young People: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Barriers to, and facilitators for, supporting learning needs of looked-after children and young people: Looked-After Children and Young People: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Barriers to, and facilitators for, supporting looked-after children and young people in transition out of care to living with their adoptive or birth parents or special guardians, or into connected care: Looked-After Children and Young People: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Evidence reviews for the non-pharmacological management of ME/CFS: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Identifying and diagnosing ME/CFS: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2021.
- Information, education and support for health and social care professionals: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Information, education and support for people with ME/CFS and their families and carers: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2021.
- Interventions and approaches to support looked-after young people transitioning out of care into independent living: Looked-After Children and Young People: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Interventions and approaches to support practitioners in completing physical and mental health and wellbeing assessments (and act on findings during the care journey) for looked-after children and young people: Looked-After Children and Young People: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Interventions to promote physical, mental, and emotional health and wellbeing of looked-after children, young people and care leavers: Looked-After Children and Young People: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Interventions to support care placement stability for looked-after children and young people: Looked-After Children and Young People: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Interventions to support entry into further or higher education or training in looked-after children and young people: Looked-After Children and Young People: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Interventions to support learning needs for school-aged looked-after children and young people: Looked-After Children and Young People: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Interventions to support looked-after children and young people transitioning out of care to living with adoptive or birth parents or special guardians, or into connected care: Looked-After Children and Young People: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Interventions to support positive relationships for looked-after children, young people and care leavers: Looked-After Children and Young People: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Interventions to support readiness for school in looked-after children and young people: Looked-After Children and Young People: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); October 2021.
- Management strategies before diagnosis: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2021.
- Monitoring and reviewing people with ME/CFS: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2021.
- Multidisciplinary care: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2021.
- Pharmacological interventions: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2021.
- Evidence review for doxycycline: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); September 2021.
- Evidence review for VTE prevention in COVID-19: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); September 2021.
- Accessing antenatal care: Antenatal care: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Accessing healthcare: Babies, children and young people’s experience of healthcare: Evidence review ONational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Adherence: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review NNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Antenatal classes: Antenatal care: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Approaches to information provision: Antenatal care: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Assessment tools for people with suspected OSAHS, OHS or COPD–OSAHS overlap syndrome: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Communication by healthcare staff: Babies, children and young people’s experience of healthcare: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Consent, privacy and confidentiality: Babies, children and young people’s experience of healthcare: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Content of antenatal appointments: Antenatal care: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Continuity of care: Babies, children and young people’s experience of healthcare: Evidence review PNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- CPAP devices for the treatment of mild OSAHS: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Demonstration of efficacy: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review MNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Design of healthcare services: Babies, children and young people’s experience of healthcare: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Diagnostic tests for OSAHS, OHS and COPD–OSAHS overlap syndrome: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Empowering children and young people to advocate for themselves: Babies, children and young people’s experience of healthcare: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence review for defining clinically significant decline in eGFR in terms of risk of kidney disease progression: Chronic kidney disease: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence review for optimal blood pressure targets for adults, children and young people with CKD: Chronic kidney disease: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence review for optimal monitoring frequency: Chronic kidney disease: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence review for the accuracy of albumin: creatinine ratio versus protein creatinine ratio measurements to quantify proteinuria in children and young people with CKD: Chronic kidney disease: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence review for the best combination of measures to identify increased risk of progression in adults, children and young people: Chronic kidney disease: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence reviews for accuracy of reagent strips for detecting protein and blood in urine in children and young people with CKD: Chronic kidney disease: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence reviews for aspirational haemoglobin target range for children and young people with CKD: Chronic kidney disease: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence reviews for children and young people who should be tested for CKD: Chronic kidney disease: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence reviews for criteria for referral, admission, oxygen supplementation, and discharge: Bronchiolitis in children: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence reviews for cystatin C based equations to estimate GFR in adults, children and young people: Chronic kidney disease: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence reviews for eGFR threshold for the investigation of anaemia due to chronic kidney disease: Chronic kidney disease: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence reviews for interventions to lower proteinuria: Chronic kidney disease: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence reviews for managing anaemia with IV iron in people with GFR category G5 who are on dialysis: Chronic kidney disease: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence reviews for the diagnostic accuracy of eGFR calculations in adults, children, and young people from black, Asian and other minority ethnic groups with CKD: Chronic kidney disease: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Evidence reviews for the use of phosphate binders: Chronic kidney disease: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); August 2021.
- Fetal movement monitoring: Antenatal care: Evidence review PNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Healthcare environment: Babies, children and young people’s experience of healthcare: Evidence review MNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Identification of breech presentation: Antenatal care: Evidence review LNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Identification of hypertension in pregnancy: Antenatal care: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Improving experience of healthcare: Babies, children and young people’s experience of healthcare: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Independent advocacy in healthcare for children and young people: Babies, children and young people’s experience of healthcare: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Information and support: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review ONational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Information provision: Antenatal care: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Involving parents or carers in healthcare and healthcare decisions: Babies, children and young people’s experience of healthcare: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Involving partners: Antenatal care: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Management of breech presentation: Antenatal care: Evidence review MNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Management of heartburn in pregnancy: Antenatal care: Evidence review SNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Management of nausea and vomiting in pregnancy: Antenatal care: Evidence review RNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Management of pelvic girdle pain in pregnancy: Antenatal care: Evidence review UNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Management of symptomatic vaginal discharge in pregnancy: Antenatal care: Evidence review TNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Management of unexplained vaginal bleeding in pregnancy: Antenatal care: Evidence review VNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Maternal sleep position during pregnancy: Antenatal care: Evidence review WNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Measuring experience: Babies, children and young people’s experience of healthcare: Evidence review LNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Monitoring fetal growth: Antenatal care: Evidence review ONational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Monitoring: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review LNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Number of antenatal appointments: Antenatal care: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Oral devices: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Oxygen therapy: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Peer support: Antenatal care: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Planning healthcare and making shared decisions: Babies, children and young people’s experience of healthcare: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Positional modifiers: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Positive airway pressure therapy variants for OSAHS, OHS and COPD–OSAHS overlap syndrome: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Prioritisation for rapid assessment at a sleep centre of people with suspected OSAHS, OHS or COPD–OSAHS overlap syndrome: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Providing information: Babies, children and young people’s experience of healthcare: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Referral and delivery of antenatal care: Antenatal care: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Rhinitis: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Risk factors for venous thromboembolism in pregnancy: Antenatal care: Evidence review NNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Routine third trimester ultrasound for fetal growth: Antenatal care: Evidence review QNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Support from healthcare staff: Babies, children and young people’s experiences of healthcare: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Supporting participation in usual activities: Babies, children and young people’s experience of healthcare: Evidence review NNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Surgery: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Timing of first antenatal appointment: Antenatal care: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- Understanding the risks and benefits of healthcare decisions: Babies, children and young people’s experience of healthcare: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
- When to suspect OSAHS, OHS and COPD–OSAHS overlap syndrome: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2021.
-
Clostridioides difficile infection: antimicrobial prescribing guideline: Evidence reviewLondon: National Institute for Health and Care Excellence (NICE); July 2021.
- Evidence reviews for long-acting insulins in type 1 diabetes: Type 1 diabetes in adults: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); July 2021.
- Addition of oral corticosteroids to oral isotretinoin for the treatment of severe inflammatory acne vulgaris: Acne vulgaris: management: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Dietary interventions for the treatment of acne vulgaris: Acne vulgaris: management: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Evidence review for azithromycin: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); June 2021.
- Evidence review for decision aids for people facing health treatment or screening decisions: Shared decision making: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); June 2021.
- Evidence review for effective approaches and activities to normalise shared decision making in the healthcare system: Shared decision making: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); June 2021.
- Evidence review for effectiveness of approaches and activities to increase engagement in shared decision making and the barriers and facilitators to engagement: Shared decision making: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); June 2021.
- Evidence review for interventions to support effective shared decision making: Shared decision making: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); June 2021.
- Evidence review for risk communication: Shared decision making: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); June 2021.
- Evidence review for risk factors for scarring due to acne vulgaris: Acne vulgaris: management: Evidence review LNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Information and support: Acne vulgaris: management: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Intralesional corticosteroids for the treatment of individual acne vulgaris lesions: Acne vulgaris: management: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Maintenance treatments for acne vulgaris: Acne vulgaris: management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); June 2021.
- Management of acne vulgaris-associated scarring: Acne vulgaris: management: Evidence review MNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Management options for mild to moderate acne – network meta-analyses: Acne vulgaris: management: Evidence review E1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Management options for mild to moderate acne – pairwise comparisons: Acne vulgaris: management: Evidence review E2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Management options for moderate to severe acne – network meta-analyses: Acne vulgaris: management: Evidence review F1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Management options for moderate to severe acne – pairwise comparisons: Acne vulgaris: management: Evidence review F2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Management options for people with acne vulgaris and polycystic ovary syndrome: Acne vulgaris: management: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Management options for refractory acne: Acne vulgaris: management: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Referral to specialist care: Acne vulgaris: management: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Skin care advice for people with acne vulgaris: Acne vulgaris: management: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2021.
- Ablation: Atrial fibrillation: diagnosis and management: Cost-effectiveness analysis J3National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Ablation: Atrial fibrillation: diagnosis and management: Evidence review J1National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Ablation: Atrial fibrillation: diagnosis and management: Network meta-analysis J2National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Accuracy of tests for detection: Atrial fibrillation: diagnosis and management: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Antiarrhythmic drugs after ablation: Atrial fibrillation: diagnosis and management: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Anticoagulant therapy for stroke prevention in people with atrial fibrillation: Atrial fibrillation: diagnosis and management: Evidence review G1National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Assessment of secondary postpartum haemorrhage: Postnatal care: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Benefits and harms of bed sharing: Postnatal care: Evidence review MNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Breastfeeding facilitators and barriers: Postnatal care: Evidence review QNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Breastfeeding information and support: Postnatal care: Evidence review SNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Breastfeeding interventions: Postnatal care: Evidence review PNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Co-sleeping risk factors: Postnatal care: Evidence review NNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Content of postnatal care contacts: Postnatal care: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Discontinuing anticoagulation in people whose atrial fibrillation has resolved: Atrial fibrillation: diagnosis and management: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Effectiveness of tests for detection: Atrial fibrillation: diagnosis and management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Emotional attachment: Postnatal care: Evidence review ONational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for acupuncture for chronic primary pain: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for antibiotic-impregnated catheters for reducing late-onset neonatal infection: Neonatal infection: antibiotics for prevention and treatment: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for antibiotics for treating late-onset neonatal infection: Neonatal infection: antibiotics for prevention and treatment: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for communication between healthcare professionals and people with chronic pain (chronic primary pain and chronic secondary pain): Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for corticosteroids: NICE COVID-19 rapid guideline: managing COVID-19: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for electrical physical modalities for chronic primary pain: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for exercise for chronic primary pain: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for information and support for parents and carers of babies with late-onset neonatal infection: Neonatal infection: antibiotics for prevention and treatment: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for intrapartum antibiotic prophylaxis for reducing early-onset neonatal infection: Neonatal infection: antibiotics for prevention and treatment: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for investigations before starting treatment for late-onset neonatal infection: Neonatal infection: antibiotics for prevention and treatment: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for manual therapy for chronic primary pain: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for pain management programmes for chronic pain (chronic primary pain and chronic secondary pain): Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for pharmacological management for chronic primary pain: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for psychological therapy for chronic primary pain: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for social interventions for chronic pain (chronic primary pain and chronic secondary pain): Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence review for timing of delivery to reduce the risk of early-onset neonatal infection: Neonatal infection: antibiotics for prevention and treatment: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence reviews for antifungal prophylaxisfor treating late-onset neonatal infection: Neonatal infection: antibiotics for prevention and treatment: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence reviews for factors that may be barriers to successfully managing chronic pain (chronic primary pain and chronic secondary pain): Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence reviews for maternal and neonatal risk factors for early-onset neonatal infection: Neonatal infection: antibiotics for prevention and treatment: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); April 2021.
- Evidence reviews for maternal and neonatal risk factors for late-onset neonatal infection: Neonatal infection: antibiotics for prevention and treatment: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); April 2021.
- Formula feeding information and support: Postnatal care: Evidence review TNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Information for lactation suppression: Postnatal care: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Information transfer: Postnatal care: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Length of postpartum stay: Postnatal care: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Non-ablative rate control therapies: Atrial fibrillation: diagnosis and management: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Perineal pain: Postnatal care: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Provision of information about the postnatal health of women: Postnatal care: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Risk stratification tools for predicting bleeding events in people with atrial fibrillation: Atrial fibrillation: diagnosis and management: Evidence reviews E&FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Scoring systems for illness in babies: Postnatal care: Evidence review L2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Signs and symptoms of serious illness in babies: Postnatal care: Evidence review L1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Statins for preventing atrial fibrillation after cardiothoracic surgery: Atrial fibrillation: diagnosis and management: Evidence review MNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Timing of comprehensive assessment: Postnatal care: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Timing of first postnatal contact by health visitor: Postnatal care: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Timing of first postnatal contact by midwife: Postnatal care: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Tools for predicting breastfeeding difficulties: Postnatal care: Evidence review RNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Tools for the clinical review of women: Postnatal care: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Tools to predict stroke in people with atrial fibrillation: Atrial fibrillation: diagnosis and management: Evidence reviews C and DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- Treatment strategies for atrial fibrillation after cardiothoracic surgery: Atrial fibrillation: diagnosis and management: Evidence review LNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2021.
- The benefits and risks of planned caesarean birth: Caesarean birth: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2021.
- Methods to reduce infectious morbidity at caesarean birth: Caesarean birth: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2021.
- Monitoring after intrathecal or epidural opioids for caesarean birth: Caesarean birth: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2021.
- Opioids for pain relief after caesarean birth: Caesarean birth: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2021.
- Prevention and management of hypothermia and shivering: Caesarean birth: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2021.
- Techniques to close the uterus at caesarean birth: Caesarean birth: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2021.
- The effects of systemic anticancer treatment (SACT) or radiotherapy on risk of severe illness or death in patients with cancer and COVID-19: Rapid evidence reviewLondon: National Institute for Health and Care Excellence (NICE); February 2021.
- Continuous glucose monitoring: Diabetes in pregnancy: management from preconception to the postnatal period: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); December 2020.
- COVID-19 rapid evidence review: managing the long-term effects of COVID-19 (NG188): Evidence review 8: service organisationLondon: National Institute for Health and Care Excellence (NICE); December 2020.
- COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188): Evidence review 1: risk factorsLondon: National Institute for Health and Care Excellence (NICE); December 2020.
- COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188): Evidence review 4: investigationsLondon: National Institute for Health and Care Excellence (NICE); December 2020.
- COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188): Evidence review 5: interventionsLondon: National Institute for Health and Care Excellence (NICE); December 2020.
- COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188): Evidence reviews 2 and 3: prevalenceLondon: National Institute for Health and Care Excellence (NICE); December 2020.
- COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188): Evidence reviews 6 and 7: monitoring and referralLondon: National Institute for Health and Care Excellence (NICE); December 2020.
- Evidence reviews for fluid therapy for the management of diabetic ketoacidosis: Diabetes (type 1 and type 2) in children and young people: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); December 2020.
- Evidence reviews for the use of vitamin D supplementation as prevention and treatment of COVID-19: Vitamin D for COVID-19: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); December 2020.
- The views and experiences of patients, their families and carers: COVID-19 rapid evidence review: Managing the long-term effects of COVID-19: Evidence reviewEdinburgh: Healthcare Improvement Scotland; December 2020.
- COVID-19 rapid evidence review: reducing the risk of venous thromboembolism in over 16sLondon: National Institute for Health and Care Excellence (NICE); November 2020.
- Evidence review for antiplatelet therapy for people with an ongoing separate indication for anticoagulation: Acute coronary syndrome: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2020.
- Evidence review for antithrombin therapy in adults with ST-segment elevation myocardial infarction intended for primary percutaneous coronary intervention: Acute Coronary Syndromes: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2020.
- Evidence review for antithrombin therapy: Acute Coronary Syndromes: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2020.
- Evidence review for beta-blockers: Acute coronary syndromes: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2020.
- Evidence review for culprit vessel only compared to complete revascularisation: Acute Coronary Syndromes: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2020.
- Evidence review for dual antiplatelet therapy: Acute Coronary Syndromes: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2020.
- Evidence review for early invasive versus conservative management: Acute Coronary Syndromes: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2020.
- Evidence review for the clinical and cost-effectiveness of drug-eluting stents: Acute coronary syndromes: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2020.
- Evidence review for pharmacological management of sciatica: Low back pain and sciatica in over 16s: assessment and management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); September 2020.
- Barriers in accessing rehabilitation services: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Collaborative care planning: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Comparative effectiveness of different types of rehabilitation services: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- COVID-19 rapid guideline: arranging planned care in hospitals and diagnostic services: Evidence summary and evidence tablesLondon: National Institute for Health and Care Excellence (NICE); August 2020.
- Effective interventions for improving engagement in addressing substance misuse: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review ONational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Effectiveness of rehabilitation services: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for blood glucose control management: Perioperative care in adults: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for enhanced recovery programmes: Perioperative care in adults: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for information and support needs: Perioperative care in adults: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for intravenous fluid management strategy: Perioperative care in adults: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for management of anticoagulant medication: Perioperative care in adults: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for management systems to promote safety in operating theatres: Perioperative care in adults: Evidence review LNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for non-invasive cardiac output monitoring: Perioperative care in adults: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for nutritional screening in preoperative assessment: Perioperative care in adults: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for postoperative recovery in specialist areas: Perioperative care in adults: Evidence review MNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for pre-operative fasting: Perioperative care in adults: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for preoperative management of anaemia: Perioperative care in adults: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for preoperative optimisation clinics in older adults: Perioperative care in adults: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for preoperative risk stratification tools: Perioperative care in adults: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence reviews for managing acute postoperative pain: Perioperative care in adults: Evidence review N1National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Factors associated with successful transition through rehabilitation services: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review QNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- The features of supported accommodation and housing that promote successful community living: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review PNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Identifying people who would benefit most from mental health rehabilitation services: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Integrated rehabilitation care pathways involving multiple providers: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Interventions to improve activities of daily living: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Interventions to improve engagement in community activities: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review MNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Interventions to improve engagement in healthy living: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review NNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Interventions to improve interpersonal functioning: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review LNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Prevalence of comorbidity: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Principles to guide adjustments to standard treatment: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- The rehabilitation approaches, care, support and treatment that are valued by recipients: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Required components of an effective rehabilitation pathway: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Supporting successful transitions: Rehabilitation in adults with complex psychosis and related severe mental health conditions: Evidence review RNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2020.
- Evidence review for anaesthesia for hip replacement: Joint replacement (primary): hip, knee and shoulder: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for anaesthesia for knee replacement: Joint replacement (primary): hip, knee and shoulder: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for anaesthesia for shoulder replacement: Joint replacement (primary): hip, knee and shoulder: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for decision aids: Joint replacement (primary): hip, knee and shoulder: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for hemiarthroplasty - proximal humeral fracture: Joint replacement (primary): hip, knee and shoulder: Evidence review ONational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for hip replacement approach: Joint replacement (primary): hip, knee and shoulder: Evidence review MNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for information needs: Joint replacement (primary): hip, knee and shoulder: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for inpatient hip and knee postoperative rehabilitation: Joint replacement (primary): hip, knee and shoulder: Evidence review PNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for inpatient shoulder postoperative rehabilitation: Joint replacement (primary): hip, knee and shoulder: Evidence review QNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for long-term follow-up and monitoring: Joint replacement (primary): hip, knee and shoulder: Evidence review TNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for outpatient hip and knee postoperative rehabilitation: Joint replacement (primary): hip, knee and shoulder: Evidence review RNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for outpatient rehabilitation after shoulder replacement: Joint replacement (primary): hip, knee and shoulder: Evidence review SNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for patella resurfacing: Joint replacement (primary): hip, knee and shoulder: Evidence review LNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for preoperative rehabilitation: Joint replacement (primary): hip, knee and shoulder: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for shoulder replacement – intact rotator cuff: Joint replacement (primary): hip, knee and shoulder: Evidence review NNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for total knee replacement: Joint replacement (primary): hip, knee and shoulder: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for tranexamic acid to minimise blood loss: Joint replacement (primary): hip, knee and shoulder: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for ultra-clean air: Joint replacement (primary): hip, knee and shoulder: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for wound lavage: Joint replacement (primary): hip, knee and shoulder: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Evidence review for wrong implant selection: Joint replacement (primary): hip, knee and shoulder: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); June 2020.
- Accuracy of imaging techniques in identifying complications after surgery: Abdominal aortic aneurysm: diagnosis and management: Evidence review WLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Anaesthesia and analgesia for people having surgical repair of an abdominal aortic aneurysm: Abdominal aortic aneurysm: diagnosis and management: Evidence review LLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- CT angiography with post-processing techniques: Abdominal aortic aneurysm: diagnosis and management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Economic modelling report for pharmacological treatment in people with confirmed deep vein thrombosis and/or pulmonary embolism: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Effectiveness of endovascular aneurysm repair compared with open surgical repair of ruptured abdominal aortic aneurysms: Abdominal aortic aneurysm: diagnosis and management: Evidence review TLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Effectiveness of endovascular aneurysm repair, open surgical repair and non-surgical management of unruptured abdominal aortic aneurysms: Abdominal aortic aneurysm: diagnosis and management: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for assessing psychological impact: Tinnitus: assessment and management: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for assessing quality of life: Tinnitus: assessment and management: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for audiological assessment: Tinnitus: assessment and management: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for betahistine: Tinnitus: assessment and management: Evidence review NNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for combinations of management strategies: Tinnitus: assessment and management: Evidence review PNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for imaging to investigate the cause of non-pulsatile tinnitus: Tinnitus: assessment and management: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for imaging to investigate the cause of pulsatile tinnitus: Tinnitus: assessment and management: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for investigations for cancer in people with unprovoked venous thromboembolism: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for neuromodulation: Tinnitus: assessment and management: Evidence review ONational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for outpatient treatment of low-risk pulmonary embolism: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for patient information: Tinnitus: assessment and management: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for psychoacoustic measures: Tinnitus: assessment and management: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for psychological therapies: Tinnitus: assessment and management: Evidence review LNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for questionnaires to assess tinnitus: Tinnitus: assessment and management: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for sound therapy and amplification devices: Tinnitus: assessment and management: Evidence review MNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for the use of inferior vena caval filters in people with venous thromboembolism: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for the use of the pulmonary embolism rule-out criteria for diagnosis of pulmonary embolism: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence review for tinnitus support: Tinnitus: assessment and management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence reviews for D-dimer testing in the diagnosis of deep vein thrombosis and pulmonary embolism: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence reviews for pharmacological treatment in people with suspected or confirmed deep vein thrombosis and/or pulmonary embolism: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Evidence reviews for symptoms and features for urgent and non-urgent referral: Tinnitus: assessment and management: Evidence review C-DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2020.
- Goal-directed therapy during repair of unruptured and ruptured abdominal aortic aneurysms: Abdominal aortic aneurysm: diagnosis and management: Evidence review MLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Imaging techniques to diagnose abdominal aortic aneurysms: Abdominal aortic aneurysm: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Managing complications after abdominal aortic aneurysm repair: Abdominal aortic aneurysm: diagnosis and management: Evidence review XLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Monitoring for abdominal aortic aneurysm expansion and risk of rupture: Abdominal aortic aneurysm: diagnosis and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Non-surgical interventions for slowing aneurysm growth and reducing the risk of rupture: Abdominal aortic aneurysm: diagnosis and management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Observational evidence on the effectiveness of endovascular aneurysm repair compared with open surgical repair of unruptured abdominal aortic aneurysms: Abdominal aortic aneurysm: diagnosis and management: Evidence review K2London: National Institute for Health and Care Excellence (NICE); March 2020.
- Permissive hypotension during transfer of people with ruptured abdominal aortic aneurysm to regional vascular services: Abdominal aortic aneurysm: diagnosis and management: Evidence review QLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Postoperative surveillance after surgical repair of abdominal aortic aneurysms: Abdominal aortic aneurysm: diagnosis and management: Evidence review VLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Pre- and postoperative interventions to optimise outcomes after abdominal aortic aneurysm repair: Abdominal aortic aneurysm: diagnosis and management: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Preventing abdominal compartment syndrome following repair of ruptured abdominal aortic aneurysm: Abdominal aortic aneurysm: diagnosis and management: Evidence review ULondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Risk assessment tools for predicting surgical outcomes of patients who undergo elective abdominal aortic aneurysm repair: Abdominal aortic aneurysm: diagnosis and management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Risk factors associated with abdominal aortic aneurysm growth or rupture: Abdominal aortic aneurysm: diagnosis and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Risk factors for predicting presence of an abdominal aortic aneurysm: Abdominal aortic aneurysm: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Risk factors for predicting survival after abdominal aortic aneurysm rupture: Abdominal aortic aneurysm: diagnosis and management: Evidence review SLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Signs, symptoms and risk factors indicating suitability for transfer to a regional vascular service: Abdominal aortic aneurysm: diagnosis and management: Evidence review OLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Signs, symptoms and risk factors predicting ruptured or symptomatic unruptured aneurysms before arrival at the hospital, and in non-specialist hospital settings: Abdominal aortic aneurysm: diagnosis and management: Evidence review NLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Tests for predicting outcomes after repair of unruptured abdominal aortic aneurysms: Abdominal aortic aneurysm: diagnosis and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Thresholds for abdominal aortic aneurysm repair: Abdominal aortic aneurysm: diagnosis and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Time period for transfer to regional vascular services: Abdominal aortic aneurysm: diagnosis and management: Evidence review PLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Use of tranexamic acid during transfer of people with ruptured or symptomatic abdominal aortic aneurysm: Abdominal aortic aneurysm: diagnosis and management: Evidence review RLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- What factors determine the optimum duration of pharmacological treatment for DVT or PE in people with a VTE? Venous thromboembolic diseases: diagnosis, management and thrombophilia testing: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); March 2020.
- Acetate: Neonatal parenteral nutrition: Evidence review D6National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Amino acids: Neonatal parenteral nutrition: Evidence review D2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Energy needs: Neonatal parenteral nutrition: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- General principles: Neonatal parenteral nutrition: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Glucose: Neonatal parenteral nutrition: Evidence review D1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Increasing ICS treatment within supported self-management for children and young people: Asthma: diagnosis, monitoring and chronic asthma management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); February 2020.
- Information and support: Neonatal parenteral nutrition: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Iron: Neonatal parenteral nutrition: Evidence review D5National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Lipid emulsions: Neonatal parenteral nutrition: Evidence review D4National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Lipids: Neonatal parenteral nutrition: Evidence review D3National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Monitoring neonatal parenteral nutrition: Neonatal parenteral nutrition: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Optimal timeframe to start parenteral nutrition: Neonatal parenteral nutrition: Evidence review A2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Predictors of enteral feeding success: Neonatal parenteral nutrition: Evidence review A1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Ratio of calcium to phosphate: Neonatal parenteral nutrition: Evidence review D9National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Ratio of carbohydrates to lipids: Neonatal parenteral nutrition: Evidence review D8National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Ratio of non-nitrogen energy to nitrogen: Neonatal parenteral nutrition: Evidence review D7National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Ratio of phosphate to amino acids: Neonatal parenteral nutrition: Evidence review D10National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Service design: Neonatal parenteral nutrition: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Standardised neonatal parenteral nutrition formulations: Neonatal parenteral nutrition: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Stopping parenteral nutrition: Neonatal parenteral nutrition: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Venous access: Neonatal parenteral nutrition: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); February 2020.
- Deferral of surgery in people having neoadjuvant therapy for rectal cancer: Colorectal cancer (update): Evidence review C4National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Effectiveness of aspirin in the prevention of colorectal cancer in people with Lynch syndrome: Colorectal cancer (update): Evidence review A1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Effectiveness of exenterative surgery for locally advanced or recurrent rectal cancer: Colorectal cancer (update): Evidence review C5National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Effectiveness of stenting for acute large bowel obstruction: Colorectal cancer (update): Evidence review C9National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Endoscopic resection alone for early colon cancer: Colorectal cancer (update): Evidence review C6National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Follow-up to detect recurrence after treatment for non-metastatic colorectal cancer: Colorectal cancer (update): Evidence review E1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Information needs of people prior, during and after treatment for colorectal cancer: Colorectal cancer update: Evidence review E3National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Local and systemic treatments for metastatic colorectal cancer isolated in the peritoneum: Colorectal cancer (update): Evidence review D4National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Optimal combination and sequence of treatments in patients presenting with metastatic colorectal cancer in the liver not amenable to treatment with curative intent: Colorectal cancer (update): Evidence review D2bNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Optimal duration of adjuvant chemotherapy for colorectal cancer: Colorectal cancer (update): Evidence review C8National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Optimal management of low anterior resection syndrome: Colorectal cancer (update): Evidence review E2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Optimal surgical technique for rectal cancer: Colorectal cancer (update): Evidence review C3National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Preoperative chemotherapy for non-metastatic colon cancer: Colorectal cancer (update): Evidence review C7National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Preoperative radiotherapy and chemoradiotherapy for rectal cancer: Colorectal cancer (update): Evidence review C2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Surgery for asymptomatic primary tumour: Colorectal cancer (update): Evidence review D1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Surgical volumes and outcomes for rectal cancer: Colorectal cancer (update): Evidence review F1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Treatment for early rectal cancer: Colorectal cancer (update): Evidence review C1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Treatment for metastatic colorectal cancer in the liver amenable to treatment with curative intent: Colorectal cancer (update): Evidence review D2aNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Treatment for metastatic colorectal cancer in the lung amenable to local treatment: Colorectal cancer (update): Evidence review D3National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Use of molecular biomarkers to guide systemic therapy: Colorectal cancer (update): Evidence review B1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2020.
- Evidence review for preventing contrast-induced acute kidney injury: Acute kidney injury: prevention, detection and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); December 2019.
- Evidence review for chronic pain: Cannabis-based medicinal products: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for diagnosis of diverticular disease: Diverticular disease: diagnosis and management: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for diagnostic tests for acute diverticulitis: Diverticular disease: diagnosis and management: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for epilepsy: Cannabis-based medicinal products: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for indications for surgery: Diverticular disease: diagnosis and management: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for information and support: Diverticular disease: diagnosis and management: Evidence review QNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for intractable nausea and vomiting: Cannabis-based medicinal products: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for laparoscopic lavage for the management of bowel perforations: Diverticular disease: diagnosis and management: Evidence review ONational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for laparoscopic versus open sigmoid resection for acute diverticulitis: Diverticular disease: diagnosis and management: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for management of diverticular disease: Diverticular disease: diagnosis and management: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for management of recurrent acute diverticulitis: Diverticular disease: diagnosis and management: Evidence review PNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for management of recurrent diverticular disease: Diverticular disease: diagnosis and management: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for non-surgical management of acute diverticulitis: Diverticular disease: diagnosis and management: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for percutaneous drainage versus resectional surgery for the management of abscesses: Diverticular disease: diagnosis and management: Evidence review NNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for prevention of diverticular disease in patients with diverticulosis: Diverticular disease: diagnosis and management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for primary versus secondary anastomosis (timing of anastomosis) in complicated acute diverticulitis: Diverticular disease: diagnosis and management: Evidence review MNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for referral criteria for acute diverticulitis: Diverticular disease: diagnosis and management: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for signs and symptoms predicting Kawasaki disease: Fever in under 5s: assessment and initial management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for spasticity: Cannabis-based medicinal products: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for symptoms and signs of diverticular disease: Diverticular disease: diagnosis and management: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for the management of complicated acute diverticulitis – extent of colectomy: Diverticular disease: diagnosis and management: Evidence review LNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence review for timing of surgery for complicated acute diverticulitis: Diverticular disease: diagnosis and management: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Evidence reviews for prescribing cannabis-based medicinal products: Cannabis-based medicinal products: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); November 2019.
- Imaging for fine needle aspiration: Thyroid disease: assessment and management: Evidence review NNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Indications for testing: Thyroid disease: assessment and management: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Information for people with thyroid disease: Thyroid disease: assessment and management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Management of hypothyroidism: Thyroid disease: assessment and management: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Management of non-malignant thyroid enlargement: Thyroid disease: assessment and management: Evidence review PNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Management of subclinical hypothyroidism: Thyroid disease: assessment and management: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Management of subclinical thyrotoxicosis: Thyroid disease: assessment and management: Evidence review MNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Management of thyrotoxicosis: - drugs vs surgery vs radioactive iodine - safety of treatment with radioactive iodine: Thyroid disease: assessment and management: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Management of thyrotoxicosis: anti thyroid drugs: Thyroid disease: assessment and management: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Management of thyrotoxicosis: radioactive iodine options: Thyroid disease: assessment and management: Evidence review LNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Management of thyrotoxicosis: surgical options: Thyroid disease: assessment and management: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Monitoring thyroid disease: Thyroid disease: assessment and management: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Tests for people with confirmed primary hypothyroidism: Thyroid disease: assessment and management: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Tests for people with confirmed thyrotoxicosis: Thyroid disease: assessment and management: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Thyroid function tests: Thyroid disease: assessment and management: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Ultrasound guidance for fine needle aspiration: Thyroid disease: assessment and management: Evidence review ONational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); November 2019.
- Diabetic foot infection: antimicrobial prescribingLondon: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Additional services and inappropriate admissions: End of life care for adults: service delivery: Evidence review LNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Advance care planning: End of life care for adults: service delivery: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Barriers to accessing end of life care services: End of life care for adults: service delivery: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Care coordinator and lead healthcare professional: End of life care for adults: service delivery: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Carer support services: End of life care for adults: service delivery: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Information sharing: End of life care for adults: service delivery: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Involving carers: End of life care for adults: service delivery: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Multiprofessional team: End of life care for adults: service delivery: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Optimal transition and facilitating discharge: End of life care for adults: service delivery: Evidence review MNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Out of hours services: End of life care for adults: service delivery: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Service provision: identifying the need for additional services; timing and frequency of review of services: End of life care for adults: service delivery: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: Timing of referral to palliative care services: End of life care for adults: service delivery: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Evidence review: What are the best service models to support the identification of people who may be entering the last year of life? End of life care for adults: service delivery: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2019.
- Abortion before ultrasound evidence: Abortion care: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Accessibility and sustainability of abortion services: Abortion care: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Anaesthesia or sedation for surgical abortion: Abortion care: Evidence review NNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Anti-D prophylaxis for women up to 13+6 weeks’ gestation: Abortion care: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Antibiotic prophylaxis for medical and surgical abortion: Abortion care: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Cervical priming before surgical abortion: Abortion care: Evidence review MNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Contraception after abortion: Abortion care: Evidence review PNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Evidence review for fetal monitoring during labour: Twin and Triplet Pregnancy: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Evidence review for interventions for the prevention of spontaneous preterm birth: Twin and Triplet Pregnancy: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Evidence review for mode of birth: Twin and Triplet Pregnancy: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Evidence review for the optimal method of analgesia and anaesthesia during labour and birth: Twin and Triplet Pregnancy: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Evidence review for the optimal screening programme to detect fetal growth restriction (intrauterine growth restriction) in twin and triplet pregnancy: Twin and Triplet Pregnancy: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Evidence review for timing of birth: Twin and Triplet Pregnancy: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Evidence review for ultrasound screening for feto-fetal transfusion syndrome: Twin and Triplet Pregnancy: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Evidence review for ultrasound screening for prediction of the risk of spontaneous preterm birth: Twin and Triplet Pregnancy: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Evidence review for ultrasound screening for twin anaemia polycythaemia sequences: Twin and Triplet Pregnancy: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Evidence reviews for interventions to prevent postpartum haemorrhage in the third stage of labour: Twin and Triplet Pregnancy: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Expulsion at home for early medical abortion: Abortion care: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Follow-up after medical abortion up to 10+0 weeks: Abortion care: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Information needs of women undergoing an abortion: Abortion care: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Medical abortion after 24 weeks’ gestation: Abortion care: Evidence review LNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Medical versus surgical abortion between 13+0 and 24+0 weeks’ gestation: Abortion care: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Misoprostol after mifepristone for inducing medical abortion between 10+1 and 24+0 weeks’ gestation: Abortion care: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Simultaneous versus delayed mifepristone + misoprostol administration for medical abortion up to 10+0 weeks’ gestation: Abortion care: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Support after abortion: Abortion care: Evidence review ONational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- VTE prophylaxis for women having abortion: Abortion care: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); September 2019.
- Evidence review for diagnosis: Hypertension in adults: diagnosis and management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2019.
- Evidence review for initiating treatment: Hypertension in adults: diagnosis and management: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2019.
- Evidence review for monitoring: Hypertension in adults: diagnosis and management: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2019.
- Evidence review for relaxation therapies: Hypertension in adults: diagnosis and management: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2019.
- Evidence review for same-day specialist review: Hypertension in adults: diagnosis and management: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2019.
- Evidence review for step 1 treatment: Hypertension in adults: diagnosis and management: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2019.
- Evidence review for step 2 and step 3 treatment: Hypertension in adults: diagnosis and management: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2019.
- Evidence review for step 4 treatment: Hypertension in adults: diagnosis and management: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2019.
- Evidence review for targets: Hypertension in adults: diagnosis and management: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); August 2019.
- Preterm labour and birth [A] Evidence review for clinical effectiveness of prophylactic progesterone in preventing preterm labourNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); August 2019.
- Economic model report for inhaled triple therapy: Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Evidence review KLondon: National Institute for Health and Care Excellence (NICE); July 2019.
- Evidence reviews for the length of corticosteroid use during exacerbations: Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Evidence review JLondon: National Institute for Health and Care Excellence (NICE); July 2019.
- Inhaled triple therapy: Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Evidence review ILondon: National Institute for Health and Care Excellence (NICE); July 2019.
- Evidence review for advice at discharge: Hypertension in pregnancy: diagnosis and management: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2019.
- Evidence review for assessment of proteinuria: Hypertension in pregnancy: diagnosis and management: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2019.
- Evidence review for interventions for chronic hypertension: Hypertension in pregnancy: diagnosis and management: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2019.
- Evidence review for interventions for pre-eclampsia: Hypertension in pregnancy: diagnosis and management: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2019.
- Evidence review for monitoring gestational hypertension: Hypertension in pregnancy: diagnosis and management: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2019.
- Evidence review for postnatal management of hypertension: Hypertension in pregnancy: diagnosis and management: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2019.
- Evidence review for prediction of complications in pre-eclampsia: Hypertension in pregnancy: diagnosis and management: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); June 2019.
- Psychological interventions for the treatment of depression: Depression in children and young people, 2019 evidence review: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); June 2019.
- Evidence review for active surveillance, radical prostatectomy or radical radiotherapy in people with localised prostate cancer: Prostate cancer: diagnosis and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for aspirin: Stroke and transient ischaemic attack in over 16s: diagnosis and initial management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for bisphosphonates: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for bisphosphonates: Prostate cancer: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for calcimimetics: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for decompressive hemicraniectomy: Stroke and transient ischaemic attack in over 16s: diagnosis and initial management: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for diagnosing and identifying clinically significant prostate cancer: Prostate cancer: diagnosis and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for Diagnostic Tests: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for docetaxel in people with hormone-sensitive prostate cancer: Prostate cancer: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for follow-up protocols after radical treatment: Prostate cancer: diagnosis and management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for following up people at risk of prostate cancer: Prostate cancer: diagnosis and management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for head positioning: Stroke and transient ischaemic attack in over 16s: diagnosis and initial management: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for identifying prostate cancer clinical progression in people with low- to intermediate-risk cancer: Prostate cancer: diagnosis and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for indications for diagnostic testing: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for indications for surgery: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for maintenance of homeostasis: Stroke and transient ischaemic attack in over 16s: diagnosis and initial management: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for management options in failed primary surgery: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for monitoring: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for patient information: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for post-surgical maintenance of remission: Crohn's disease: management: Evidence reviewLondon: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for pregnancy: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for radical radiotherapy: Prostate cancer: diagnosis and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for surgical interventions: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for surgical localisation: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for thrombectomy: Stroke and transient ischaemic attack in over 16s: diagnosis and initial management: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for TIA imaging: Stroke and transient ischaemic attack in over 16s: diagnosis and initial management: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for transient ischaemic attack (TIA) prediction rules: Stroke and transient ischaemic attack in over 16s: diagnosis and initial management: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence review for very early mobilisation: Stroke and transient ischaemic attack in over 16s: diagnosis and initial management: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); May 2019.
- Evidence reviews for induction of remission in mild-to-moderate ulcerative colitis: Ulcerative colitis: management: Evidence reviewLondon: National Institute for Health and Care Excellence (NICE); May 2019.
- Diagnostic accuracy of ultrasound features for tubal ectopic pregnancy: Ectopic pregnancy and miscarriage: diagnosis and initial management: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for application of intraoperative topical antiseptics and antibiotics before wound closure: Surgical site infections: prevention and treatment: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for assessing mesh complications after pelvic floor mesh surgery: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for assessing pelvic organ prolapse: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for diagnosing respiratory disorders: Specialist neonatal respiratory care for babies born preterm: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for effectiveness of multidisciplinary teams for the assessment and management of urinary incontinence or pelvic organ prolapse: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for effectiveness of nasal decolonisation in prevention of surgical site infection: Surgical site infections: prevention and treatment: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for management of mesh complications: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review LNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for surgical management of pelvic organ prolapse and stress urinary incontinence: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for the effectiveness of closure materials and techniques in the prevention of surgical site infection: Surgical site infections: prevention and treatment: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for the effectiveness of skin antiseptics in the prevention of surgical site infection: Surgical site infections: prevention and treatment: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for treatment options for women using absorbent containment products: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review for urodynamic assessment prior to primary surgery for stress urinary incontinence: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence review on the risks to cognitive function for women taking anticholinergic drugs for overactive bladder: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence reviews for discharge planning: Specialist neonatal respiratory care for babies born preterm: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence reviews for involving and supporting parents and carers: Specialist neonatal respiratory care for babies born preterm: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence reviews for lifestyle and conservative management options for pelvic organ prolapse: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence reviews for managing respiratory disorders: Specialist neonatal respiratory care for babies born preterm: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence reviews for monitoring: Specialist neonatal respiratory care for babies born preterm: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence reviews for respiratory support: Specialist neonatal respiratory care for babies born preterm: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence reviews for sedation and analgesia: Specialist neonatal respiratory care for babies born preterm: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence reviews for surgical and physical management of stress urinary incontinence: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence reviews for surgical management of pelvic organ prolapse: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Evidence reviews for the management of overactive bladder: Urinary incontinence and pelvic organ prolapse in women: management: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Expectant versus medical management of tubal ectopic pregnancy: Ectopic pregnancy and miscarriage: diagnosis and initial management: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); April 2019.
- Development of a systemic anti-cancer therapy algorithm: Lung cancer: diagnosis and management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for antenatal care planning involving a multidisciplinary team for women with existing medical conditions: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for breech presenting in labour: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review ONational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for information for women with existing medical conditions: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for information for women with obstetric complications or no antenatal care: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for intrapartum haemorrhage: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review NNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for labour after 42 weeks of pregnancy: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review TNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for large-for-gestational age baby: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review QNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for long-term systemic steroids: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for no antenatal care: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review RNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for previous caesarean section: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review SNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for risk assessment for women with obstetric complications or no antenatal care: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence review for small-for-gestational age baby: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review PNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for acute kidney injury or chronic kidney disease: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for asthma: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for bleeding disorders: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for effectiveness of non-ultrasound-guided TBNA, EBUS-TBNA or EUS-FNA for people with a probability of mediastinal malignancy: Lung cancer: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for heart disease: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for obesity: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for pyrexia: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review LNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for sepsis: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review MNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for subarachnoid haemorrhage or arterio-venous malformation of the brain: Intrapartum care for women with existing medical conditions or obstetric complications and their babies: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for the clinical and cost effectiveness of different radiotherapy regimens with curative intent for NSCLC: Lung cancer: diagnosis and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for the clinical and cost effectiveness of treatment regimen for the treatment of operable Stage IIIA-N2 NSCLC: Lung cancer: diagnosis and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for the clinical and cost-effectiveness of first use of thoracic radiotherapy for people with extensive-stage SCLC who have had first-line treatment with systemic anti-cancer therapies: Lung cancer: diagnosis and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for the clinical and cost-effectiveness of prophylactic cranial irradiation to prevent brain metastases in people with extensive SCLC: Lung cancer: diagnosis and management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for the clinical and cost-effectiveness of routine MRI or CT of the brain in the management of people with lung cancer prior to therapy with curative intent: Lung cancer: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); March 2019.
- Evidence reviews for the most clinically and cost-effective regimen of chemoradiotherapy for people with limited-stage SCLC: Lung cancer: diagnosis and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); March 2019.
- Assessing and monitoring complications and comorbidities: Disorders of bones and joints: Cerebral palsy in adults: Evidence review B1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Assessing and monitoring complications and comorbidities: feeding and nutritional problems: Cerebral palsy in adults: Evidence review B3National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Assessing and monitoring complications and comorbidities: mental health problems: Cerebral palsy in adults: Evidence review B2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Configuration of services: service design access to primary and secondary care: Cerebral palsy in adults: Evidence review F2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Configuration of services: service design: Cerebral palsy in adults: Evidence review F1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Dietary interventions: Renal and ureteric stones: assessment and management: Intervention evidence review (C)National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Identifying and managing respiratory disorders associated with cerebral palsy: assisted ventilation: Cerebral palsy in adults: Evidence review C2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Identifying and managing respiratory disorders associated with cerebral palsy: prophylactic treatments: Cerebral palsy in adults: Evidence review C3National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Identifying and managing respiratory disorders associated with cerebral palsy: protocols for monitoring respiratory health: Cerebral palsy in adults: Evidence review C1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Identifying pain, such as musculoskeletal and gastrointestinal pain: Cerebral palsy in adults: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Imaging for diagnosis: Renal and ureteric stones: assessment and management: Diagnostic evidence review (B)National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Imaging for follow-up: Renal and ureteric stones: assessment and management: Intervention evidence review (J)National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Interventions that improve function and participation: communication: Cerebral palsy in adults: Evidence review D4National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Interventions that improve function and participation: electronic assistive technology: Cerebral palsy in adults: Evidence review D3National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Interventions that improve function and participation: physical function: Cerebral palsy in adults: Evidence review D2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Interventions that improve function and participation: vocational and independent living skills: Cerebral palsy in adults: Evidence review D1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Management of abnormal muscle tone: neurosurgical procedures to reduce spasticity: Cerebral palsy in adults: Evidence review A2National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Management of abnormal muscle tone: pharmacological treatments for spasticity: Cerebral palsy in adults: Evidence review A1National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Management of abnormal muscle tone: treatments to reduce dystonia: Cerebral palsy in adults: Evidence review A3National Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Medical expulsive therapy: Renal and ureteric stones: assessment and management: Intervention evidence review (D)National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Metabolic investigations: Renal and ureteric stones: assessment and management: Intervention evidence review (A)National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Pain management: Renal and ureteric stones: assessment and management: Intervention evidence review (E)National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Prevention of recurrence: Renal and ureteric stones: assessment and management: Intervention evidence review (K)National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Stents after surgery: Renal and ureteric stones: assessment and management: Intervention evidence review (I)National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Stents before surgery: Renal and ureteric stones: assessment and management: Intervention evidence review (H)National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Surgical treatments: Renal and ureteric stones: assessment and management: Intervention evidence review (F)National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Timing of surgery: Renal and ureteric stones: assessment and management: Intervention evidence review (G)National Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); January 2019.
- Diagnosing COPD and predicting outcomes: Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Evidence review DLondon: National Institute for Health and Care Excellence (NICE); December 2018.
- Economic model report: Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Evidence review HLondon: National Institute for Health and Care Excellence (NICE); December 2018.
- Evidence review for principles of care: Post-traumatic stress disorder: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2018.
- Evidence reviews for organisation and delivery of care for people with PTSD: Post-traumatic stress disorder: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2018.
- Evidence reviews for pharmacological interventions for the prevention and treatment of PTSD in adults: Post-traumatic stress disorder: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2018.
- Evidence reviews for pharmacological interventions for the prevention and treatment of PTSD in children: Post-traumatic stress disorder: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2018.
- Evidence reviews for psychological and psychosocial interventions for family members of people at risk of, or with, PTSD: Post-traumatic stress disorder: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2018.
- Evidence reviews for psychological, psychosocial and other non-pharmacological interventions for the prevention of PTSD in adults: Post-traumatic stress disorder: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2018.
- Evidence reviews for psychological, psychosocial and other non-pharmacological interventions for the prevention of PTSD in children: Post-traumatic stress disorder: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2018.
- Evidence reviews for psychological, psychosocial and other non-pharmacological interventions for the treatment of PTSD in adults: Post-traumatic stress disorder: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2018.
- Evidence reviews for psychological, psychosocial and other non-pharmacological interventions for the treatment of PTSD in children and young people: Post-traumatic stress disorder: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2018.
- Evidence reviews on care pathways for adults, children and young people with PTSD: Post-traumatic stress disorder: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); December 2018.
- Inhaled therapies: Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Evidence review FLondon: National Institute for Health and Care Excellence (NICE); December 2018.
- Managing pulmonary hypertension and cor pulmonale: Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); December 2018.
- Oxygen therapy in people with stable COPD: Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Evidence review BLondon: National Institute for Health and Care Excellence (NICE); December 2018.
- Predicting and preventing exacerbations: Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Evidence review ELondon: National Institute for Health and Care Excellence (NICE); December 2018.
- Referral criteria for lung volume reduction procedures, bullectomy or lung transplantation: Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Evidence review GLondon: National Institute for Health and Care Excellence (NICE); December 2018.
- Self-management interventions, education and telehealth monitoring: Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Evidence review CLondon: National Institute for Health and Care Excellence (NICE); December 2018.
- Evidence review for coordinating care: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- Evidence review for decision support interventions: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- Evidence review for dietary management and fluid restriction: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- Evidence review for frequency of review: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- Evidence review for indicators for transferring/discontinuing RRT: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- Evidence review for information, education and support: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- Evidence review for sequencing modalities of RRT: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- Evidence review for symptom recognition: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- Evidence reviews for when to create access formation and/or list for transplantation: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- How to assess people for RRT: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- Initiating RRT: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- Modalities of RRT: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- When to assess for RRT: Renal replacement therapy and conservative management: Evidence reviewNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); October 2018.
- Analgesics: Rheumatoid arthritis in adults: diagnosis and management: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- DMARDs: Rheumatoid arthritis in adults: diagnosis and management: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for adjuvant biological therapy: Early and locally advanced breast cancer: diagnosis and management: Evidence review FNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for adjuvant bisphosphonates: Early and locally advanced breast cancer: diagnosis and management: Evidence review GNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for adjuvant systemic therapy planning: Early and locally advanced breast cancer: diagnosis and management: Evidence review CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for adjuvant: Early and locally advanced breast cancer: diagnosis and management: Evidence review ENational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for breast radiotherapy: Early and locally advanced breast cancer: diagnosis and management: Evidence review HNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for endocrine therapy for invasive disease: Early and locally advanced breast cancer: diagnosis and management: Evidence review DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for lifestyle: Early and locally advanced breast cancer: diagnosis and management: Evidence review KNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for management of the positive axilla: Early and locally advanced breast cancer: diagnosis and management: Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for neoadjuvant treatment: Early and locally advanced breast cancer: diagnosis and management: Evidence review JNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for postmastectomy radiotherapy: Early and locally advanced breast cancer: diagnosis and management: Evidence review INational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for supporting people living with a brain tumour: Brain tumours (primary) and brain metastases in adults: Evidence Report DNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for surgery to the breast: Early and locally advanced breast cancer: diagnosis and management: Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for the investigation, management and follow-up of brain metastases: Brain tumours (primary) and brain metastases in adults: Evidence Report CNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for the investigation, management and follow-up of glioma: Brain tumours (primary) and brain metastases in adults: Evidence Report ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Evidence reviews for the investigation, management and follow-up of meningioma: Brain tumours (primary) and brain metastases in adults: Evidence Report BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Frequency of monitoring: Rheumatoid arthritis in adults: diagnosis and management: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Glucocorticoids: Rheumatoid arthritis in adults: diagnosis and management: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Risk factors: Rheumatoid arthritis in adults: diagnosis and management: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Target for monitoring: Rheumatoid arthritis in adults: diagnosis and management: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Treat-to-target: Rheumatoid arthritis in adults: diagnosis and management: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Ultrasound for diagnosis: Rheumatoid arthritis in adults: diagnosis and management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Ultrasound monitoring: Rheumatoid arthritis in adults: diagnosis and management: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); July 2018.
- Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over [A] Evidence reviews for treatment of advanced diseaseLondon: National Institute for Health and Care Excellence (NICE); June 2018.
- Evidence review for diagnostic accuracy of signs and symptoms: Lyme disease: diagnosis and management: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for information needs: Lyme disease: diagnosis and management: Evidence review NNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for management of acrodermatitis chronica atrophicans: Lyme disease: diagnosis and management: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for person-to-person transmission: Lyme disease: diagnosis and management: Evidence review MNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for the awareness of Lyme disease: Lyme disease: diagnosis and management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for the management of erythema migrans: Lyme disease: diagnosis and management: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for the management of Lyme arthritis: Lyme disease: diagnosis and management: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for the management of Lyme carditis: Lyme disease: diagnosis and management: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for the management of lymphocytoma: Lyme disease: diagnosis and management: Evidence review JNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for the management of neuroborreliosis: Lyme disease: diagnosis and management: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for the management of non-neurological ocular manifestations: Lyme disease: diagnosis and management: Evidence review KNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for the management of non-specific symptoms related to Lyme disease: Lyme disease: diagnosis and management: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for the management of ongoing symptoms related to Lyme disease: Lyme disease: diagnosis and management: Evidence review LNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence reviews for diagnostic tests: Lyme disease: diagnosis and management: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); April 2018.
- Evidence review for combined pharmacological and non-pharmacological treatments review: Attention deficit hyperactivity disorder: diagnosis and management: Evidence review FNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2018.
- Evidence review for safety of pharmacological treatment: Attention deficit hyperactivity disorder: diagnosis and management: Evidence review DNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2018.
- Evidence review(s) for efficacy of non-pharmacological treatment and the impact of adverse events associated with non-pharmacological treatments of ADHD: Attention deficit hyperactivity disorder: diagnosis and management: Evidence review ENational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2018.
- Evidence reviews for Adherence to treatment (pharmacological and non-pharmacological): Attention deficit hyperactivity disorder: diagnosis and management: Evidence review GNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2018.
- Evidence reviews for diagnostic test accuracy in investigation for women presenting with heavy menstrual bleeding: Heavy menstrual bleeding (update): Evidence review ANational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2018.
- Evidence reviews for Information and support for people with ADHD: Attention deficit hyperactivity disorder: diagnosis and management: Evidence review BNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2018.
- Evidence reviews for management of heavy menstrual bleeding: Heavy menstrual bleeding (update): Evidence review BNational Guideline Alliance (UK).London: National Institute for Health and Care Excellence (NICE); March 2018.
- Evidence reviews for pharmacological efficacy and sequencing pharmacological treatment: Attention deficit hyperactivity disorder: diagnosis and management: Evidence review CNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2018.
- Evidence reviews for risk factors for ADHD: Attention deficit hyperactivity disorder: diagnosis and management: Evidence review ANational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2018.
- Evidence reviews for the principles for discussion when starting, adjusting and discontinuing pharmacological treatment for ADHD: Attention deficit hyperactivity disorder: diagnosis and management: Evidence review HNational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2018.
- Type 2 diabetes in adults: management: Evidence reviews for SGLT-2 inhibitors and GLP-1 mimeticsLondon: National Institute for Health and Care Excellence (NICE); March 2018.
- Withdrawal from pharmacological treatment and drug holidays: Attention deficit hyperactivity disorder: diagnosis and management: Evidence review INational Guideline Centre (UK).London: National Institute for Health and Care Excellence (NICE); March 2018.
- Peripheral Arterial Disease: Diagnosis and Management [A] Evidence review for determining diagnosis and severity of PAD in people with diabetesLondon: National Institute for Health and Care Excellence (NICE); February 2018.
- Autism spectrum disorder in under 19s: recognition, referral and diagnosis [A] Evidence review for factors and neurodevelopmental disorders that increase the likelihood of a diagnosis of autism spectrum disorderLondon: National Institute for Health and Care Excellence (NICE); December 2017.
- Familial hypercholesterolaemia: identification and management: Evidence reviews for case-finding, diagnosis and statin monotherapyLondon: National Institute for Health and Care Excellence (NICE); November 2017.
- Evidence review for UTI diagnosis in infants and children under 3 months and 3 months to 3 years: Urinary tract infection in under 16s: Evidence review ALondon: National Institute for Health and Care Excellence (NICE); September 2017.
- Urinary tract infection in under 16s: Evidence reviews for UTI diagnosis in under 3 yearsLondon: National Institute for Health and Care Excellence (NICE); September 2017.
- Depression in children and young people, 2015 evidence reviewLondon: National Institute for Health and Care Excellence (NICE); March 2015.
The National Institute for Health and Care Excellence was formerly known as the National Institute for Health and Clinical Excellence
- NICE Evidence Reviews CollectionNICE Evidence Reviews Collection
Your browsing activity is empty.
Activity recording is turned off.
See more...